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Background: The introduction of antiretroviral drugs generated much optimism in the survival of 
people living with HIV. The optimism had been dissipated in the light of enormous challenge 
being faced by ART patients in maintaining a perfect adherence since successful treatment is 
dependent on the maintenance of a near perfect adherence. In the context of Lesotho, there is 
hardly any study done on factors influencing adherence to antiretroviral drugs yet it is widely 
known that adherence to ART is influenced by numerous factors. These factors could be health 
system related, patients related and the medication itself. The study, therefore, sought to assess the 
factors that affect adherence to ART and also, determine the level of adherence to ART among 
people living with HIV and AIDS at Quthing District Hospital and Villa Maria Health Centre, 
Lesotho. 
Method: An analytical cross-sectional study was used to determine the predictors of adherence to 
ART among PLWHA who had been on ART for not less than three months before the study. The 
study was conducted among 382 participants between April 2016 and June 2016. 
Results: A considerable number of participants were found to comply with global adherence using 
pill count adherence, appointment adherence, and self-report as adherence instruments. Of the 382 
participants recruited for this study, the majority (63.6%) were females out of which 156 (40%) of 
them were married. The majority of the participants were on first line regimen (92.1%) and have 
been on ART for more than three years 228 (59.7%). The majority of the respondents lived in 
urban areas 296 (77.5%) and had formal education 343 (89.8%).  The results of the study indicated 
global adherence to be 85.1%.  The bivariate analysis showed significant relationships among all 
the variables. However, when subjected to multivariate analysis, three factors were significantly 
associated with global adherence to ART. These are: educational level (p<0.000; aOR = 87.9), 
knowledge of HIV status of sexual partner (p<0.020; aOR = .090), and ART perception (p<0.000; 
aOR = 0.005). 
Conclusion:  The proportion of adherent participants in this study is sub–optimal, but relatively 




especially those living in the rural areas to ensure improvement in the sub-optimal level of 
adherence obtained in this study. Thus it is important that recommendation such as health 
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CHAPTER 1: INTRODUCTION 
1.1 Background to the investigation 
Acquired immune deficiency syndrome (1) (AIDS) defining death is one of the leading causes of 
mortality in the Sub – Saharan Africa. (2)  In 2007, it was estimated that two-thirds of new infections 
occurred in Sub-Saharan Africa.(3)  An estimated 68% of the adult population and close to 90% of 
children living with HIV resides in this region. (3)  Lesotho is one of the countries in Sub – Saharan 
Africa experiencing the largest Human immunodeficiency virus (HIV) (4) and AIDS epidemic in 
the world. Research conducted in 2009 by the Lesotho Demographic and Health Survey (LDHS) 
estimated HIV prevalence to be 23.2 percent amongst people aged 15 years to 49 years. (5) 
Lesotho is a country experiencing mature epidemic with a total of new HIV infections and AIDS 
death converging to a level between 7.9% per annum.(5) The epidemic is in different stages of 
development in each district and that a different approach to addressing the epidemic in each 
district is imperative to stem the course of new infections and possibly deaths as a result. The 
increase in AIDS-related deaths typically lags behind that of new infections and converges at the 
same stable level over time. The Lesotho epidemic peaked in the late nineties and is stable at the 
moment. (5) 
1.2 Background information and rationale  
Lesotho has an enormous burden of HIV and AIDS. In 2013, an estimated 360,000  people were 
living with HIV in Lesotho (6). The epidemic accounted for about 8% and 10% of female and male 
hospital admissions in 2013, respectively.(6) HIV is a leading cause of death among adult males 
(19%) and females (21%) on hospital admission (6). Approximately 21,000 new adult infections 
and 4000 new infections among children occurred yearly from 2008 – 2009. On the average, 
11,000 women are infected yearly compared to 10,000 men.(6) HIV prevalence has stabilised in 
the general population. Modelling data show that HIV prevalence has declined among young 
women and men aged 15 – 24 years in the past six years.(6)  In Quthing district, HIV and AIDS 
epidemic remains a serious health challenge, second only to Tuberculosis (TB), and is marked by 
a prevalence rate of 21.8%. About 18.8%  individuals aged 15 years and above were estimated to 




problem, causing a developmental crisis in all the sectors of the economy. It has drastically 
affected, health, socioeconomic progress leading to a reduction in life expectancy, deepening 
poverty and exacerbating food shortages.(7, 8) 
The introduction of antiretroviral therapy in 1996 has had a significant impact on the way HIV and 
AIDS is viewed all over the world. Much as the introduction of Antiretroviral therapy (9) has not 
holistically cured HIV, the improvement in the quality of life, without a doubt, is important despite 
the presenting challenges of side effects and resistance to the medication. Antiretroviral therapy 
has managed to reduce mortality and morbidity, revitalised communities and changed the 
stereotypes that being infected with HIV and AIDS signifies death sentence rather to a chronic 
disease that is manageable. Lesotho initiated ART in 2004. Since then, remarkable progress has 
seen a rise in the sites providing ART services from 68 in 2004 to 207 sites in 2013, spread out 
across the ten districts. (6) 
In 2012, almost 23,000 new adult infections and 4,000 new infections among children occurred (6).  
In 2014, it was estimated that 160,200 adults  (aged 15+ and 20,000 children ≤ 14 years) were in 
need of ART, but only 98,379 adults and children were put on ART, which represents 
approximately 55% coverage of ART countrywide.(6)  The government of Lesotho in collaboration 
with non-governmental organisations have carried out initiatives to ensure the availability of 
ARVs and other drugs for the management of opportunistic infections. The increased accessibility 
to ARVs needs to be supported by initiatives to maximise adherence to treatment. Critical to the 
successful treatment outcome in HIV patients is adherence to antiretroviral treatment. The reason 
being that HIV is highly mutable and requires life-long treatment. Therefore, suppression of viral 
load requires complete adherence to ART. Irrational use of drugs could lead to the development 
of resistant strains which profess a grave danger to the fights against HIV and AIDS.(10) There is 
need to promote patient education and psychosocial support that will ensure people on ART adhere 
to treatment so as to prevent the development of resistant strain of HIV  as in the case of 
Tuberculosis. 
1.3 Statement of the problem 
While the government of Lesotho and other players are determined to increase accessibility to 




ARV use in the community. Currently, not much research has been done on predictors of 
adherence to antiretroviral therapy among people living with HIV and AIDS in Lesotho. Irrational 
use of ARVs have led to the emergence of HIV resistant strains, treatment failure and increased 
the cost of treatment.(5)  
Research on adherence to ART has included methodological investigations; many questions still 
need to be answered as regard ART adherence because of lack of the standardised measuring tool. 
Several studies have been conducted to measure adherence in low-income countries. In such 
settings, measurement of adherence has either been subjective such as questionnaires reporting or 
the objective method of pill counting. In some studies, a combination of the methods has been 
used.(11) 
Different studies have been done on adherence spanning across all regions. Some of the studies 
were conducted in Sub-Saharan Africa. For example, a study done on adherence using self-report 
and provider assessment in Botswana recorded a 54% and 56% adherence level respectively. The 
study further enumerated on how the patients surmounted various obstacles to adhere to treatment. 
Some of the obstacles encountered are a lack of adequate funds, travelling long distances to the 
clinics. Botswana government has taken urgent strides to make antiretroviral medication (ARVs) 
available and accessible to the populace so as to improve adherence, enhancing monitoring through 
the clinics and the laboratories and strengthening the health care delivery system.(12) 
Lesotho government has embarked on various initiatives to ensure that patients on ARVs adhere 
to treatment. Despite this, lack of proper documentation on ARV treatment adherence has been the 
bane in progress made. This is one of the problems facing Quthing District as the predictors of 
adherence are not known because of lack of documented studies. Some studies done elsewhere 
highlight a range of factors affecting adherence to ART.(13) It is, therefore, imperative that the 
research be undertaken so as to identify any possible obstacle to patients taking their medication 
to prevent the development of resistant strains of HIV and attendant treatment failure. The study 
will attempt to determine the level of adherence to ART and to establish factors associated with 





1.4 Purpose of the study 
 The study was designed to understand better and determine the level of adherence to ART and to 
document those factors associated with antiretroviral therapy adherence in Quthing District, 
Lesotho. 
1.5 Research question 
To understand the predictors of adherence to antiretroviral therapy in the context of HIV, the 
research questions created for this study were; 
 What are factors associated with adherence among PLWHA in Quthing District Hospital 
and Villa Maria Health Centre? 
 What is the level of adherence among PLWHA receiving ART from the hospital and the 
health centre? 
1.6 Research Objectives 
The objectives of this study were: 
 To establish the proportions of patients that adhere to antiretroviral therapy received from 
Quthing District Hospital and Villa Maria Health Centre in Lesotho. 
 To determine factors influencing adherence to antiretroviral therapy received from Quthing 
District Hospital and Villa Maria Health Centre in Lesotho 
 To determine the knowledge of HIV and practice of ARVs among PLWHA in Quthing 
District Hospital and Villa Maria Health Centre in Lesotho.   
1.7 Significance of the study 
The importance of the study is to improve AIDS treatment, allowing for more outpatient than 
inpatient care, and the increased life spans for persons with AIDS since HAART.  Also, the 
historical emphasis on the negative stigmatising and discrimination rather than support pointed to 
the need to focus on the predictors of adherence to antiretroviral therapy. Due to improved 
treatments, there is decreased need for hospital care for persons with AIDS.(14)  According to 




compliance with rigorous dosing, scheduling, and food requirements; b) common diarrhoea and 
gastrointestinal upset; and c) patients’ developing resistance to the drugs.  Although HIV/AIDS is 
no longer viewed as a death sentence and medications allow for care at home, there were 
considerable challenges posed by newer medications.  However, Pujol,(16) reported how 
reformulations of older medicines allow fewer pills to be taken, less frequent doses and decreased 
toxicity and side effects.  The reformulated pills are also more efficient. 
The projected impact of the epidemic is a cause for concern given the present especially in very 
high HIV-prevalence countries such as Lesotho. Knowledge gained from this study about 
predictors of adherence to ART may contribute to knowledge in health care, particularly the 
knowledge of facilitators and barriers to adherence as conceptualised by people living with HIV 
and AIDS.  HIV and AIDS affect the working population especially the young adults usually 
between 15 and 49 years. Some of those affected are heads of household who are breadwinners, 
families, and societal leaders. This scenario perpetuates poverty.(6) Therefore, there is a need for 
the government of Lesotho to redirect its resources and implement policy recommendation to 
achieve compliance of treatment to antiretroviral therapy and review health education programmes 
for people living with HIV to improve clinical management outcomes. 
 
1.8 Definition of terms   
In this study, the following terms were conceptually and operationally defined as follows:   
 Adherence:  Adherence to ART is taking all ARV medication in the correctly prescribed doses at 
the right time and in the right way while observing any dietary restriction. (3)  In this study 
adherence to ART refers to patients of Quthing District Hospital and Villa Maria Health Centre, 
who are observing the correct dosage as prescribed by the health care practitioner while following 
the instructions given. 
1.8.1 Working definition of adherence 
 Consumption of antiretroviral medication without the clients missing any dose in the past 
three months is regarded as perfect adherence (100% use). 
 Skipping minimum of one dose in a week for the previous three months is a near perfect 





 Skipping a minimum of 2 doses a week in the past three months is regarded as a modest 
adherence. (90% - 94.9% consumption of ARVs). 
 
 Low adherence is regarded in clients who in the past three months skipped more than two 
doses a week (<90% consumption of ARVs). 
 
1.8.2 Antiretroviral therapy 
 - It is a highly active antiretroviral medication that acts at different stages of the HIV life cycle to 
stop the multiplication of the virus. 
-In the present study, antiretroviral therapy refers to the treatment of HIV infection with the first-
line regimen, which is Zidovudine, Lamivudine and Nevirapine or Tenofovir fumerate and second 
line regimen which are Tenofovir, Lamivudine and Kaletra or Abacavir, Lamivudine boosted with 
Ritonavir. 
1.9 Conceptual framework for the study 
Health Belief Model is a theoretical framework commonly used in health education and health 
promotion. Developed in the early 1950s, the model is widely credited in explaining and predicting 
health behaviours.(17) The health belief model attempts to explain the rationale for individuals 
accepting or rejecting preventive measures or adopting healthy lifestyles. It was first used in 
explaining the failure of the United   States Public Health Service screening programmes. The 
model is used to engage individuals to take a preventive health action while understanding the 
motivation and decision for such health behaviours. Thus the target interventions offered by the 
health behaviour theory provides means for establishing health behaviours that are beneficial to 
the individual.  
As a result, research in medication adherence has found ways in which health behaviour can be 
changed to achieve the desired health outcome. It is in the light of this,  the theoretical framework 
guiding this research is to explain how people living with HIV and AIDS receiving ART rationalise 




seeking treatment and the reason why the use of drugs may take place or not. Although, several 
theories relating to health behaviour could be used in explaining interventions relating to individual 
cognitive factors and adherence to medication in PLWHA. The cognitive perspective of the Health 
Belief Model-guided this study. It can be used in explaining health seeking behaviour among ART 
patients. 
1.9.1 Meta-theoretical assumption 
The premise that individuals possessing a high level of self-efficacy as regards adherence to ART 
and positive attitude towards medication, in general, would most likely result in such individuals 
being motivated to adhere to ART, thereby resulting in good clinical outcome informed the meta-
theoretical assumption of this research. The assumption is premised on logic without evidence.(18) 
Widely held beliefs grounded in theory, research previously undertaken were sources of 
assumption. The hypothesis, study design and interpretation of research findings are assumption 
ingrained in research studies.(19) 
1.9.2 Health Belief Model (HBM) 
Health Belief Model attempts to explain health behaviour dealing in life expectancy relating to 
health and well-being. A group of psychologists in the 50s introduced the model and ever since, 
the model has been adapted to modify health behaviours. It has also been used by various 
researchers because the model view human as rational being capable of using cognitive and 
interpersonal approach to minimise their perceived threat such as disease symptoms while 
promoting what is viewed as beneficial to their health such as adherence to treatment.(20) 
Perception of a threat as a result of health problem, informed individuals to seek health behaviour 
that will minimise such threat and the benefits of the cue to action.(21) 
Individuals past experiences, perceived severity of the debilitating condition coupled with beliefs 
about medication and self-efficacy have been known to influence adherence. It is on this note that 
the researcher attempts to find a link between the cognitive perspective of health behaviour about 
how PLWHA interpret and evaluate their situation. It will also help to understand whether having 
self-efficacy will motivate them to adhere to treatment. Adherence to medication is often complex, 
and health knowledge and beliefs might not be sufficient to trigger behaviour change in certain 





1.10 RESEARCH DESIGN AND METHODOLOGY 
An analytical cross-sectional design was used in the study.  The success of any investigation is 
grounded in its design which dictates how the researcher want to carry out the research.(22)  A 
cross-sectional study is not expensive, and it can be carried out to examine the relationship between 
the variables without any intervention been introduced.   According to Brink (23), a quantitative 
component of research entails numerical data analysed mathematically using statistics. The aim of 
the researcher is to describe the Predictors of adherence to antiretroviral therapy among people 
living with HIV and AIDS at the Quthing District Hospital and Villa Maria Health Centre, Lesotho. 
1.10.1 Study design 
The study was conducted at Quthing District Hospital and Villa Maria Health Centre, located in 
Quthing District, Lesotho. These two sites are among a range of locations where ART is being 
provided. The District has a population of 70,792 between the ages of 15 – 49 years. Quthing 
District has one District Hospital and eight health centres. The district hospital and the Villa Maria 
Health Centre were chosen because they caters for more than 25% of ART clients in the District. 
Also, they are one of the pioneer sites for ART implementation in 2004.(24)  
1.10.2 Study population 
The study population was all adults, people living with HIV and AIDS, who were on ART 
identified from the Quthing District Hospital and Villa Maria Health Centre in the district.   
1.10.4 Sampling method  
The selection of participants was made using a simple random sampling method. The study 
respondents consisted of both males and females, 18 years or older, that have been on ART for a 
period not less than three months and were followed up. All the clients on ART that met the 
eligibility criteria were invited to participate using simple random sampling. The file number of 
all the 5000 ART patients was listed. A consecutive number of 1 to 5000 was then assigned to 




sample size calculated.  If a participant selected was ineligible or refused to participate, the next 
person on the list was selected. 
1.10.5 Sample size   
For the study of this nature to acquire the desired power, a single population proportion formula 
was used to calculate the sample size. A 50% proportion of event occurrence and 0.05 margin of 
error was used. The minimum sample size estimated based on the above assumption was 382. 
 1.10.6 Data collection  
 The questionnaire-assisted interviews in both English and Sesotho was used in collecting data. 
Participants on ART in the study settings that met the inclusion criteria were invited to participate 
while explaining the risks and benefits to the potential participants. The principal investigator 
administered the questionnaires assisted by two research assistants trained in the recruitment of 
the respondents and the administration of the questionnaires. The questionnaires assisted interview 
were conducted in private rooms, and data were collected using twenty-one questions as 
quantitative instruments during three months period (Annexure E). The independent variables 
measured in this study include; Gender, Age, Educational Status, Place of residence, Alcohol 
consumption, HIV status disclosure, HIV status knowledge, and ART perception by the 
respondents while adherence was the dependent variable. 
 1.10.7 Data Analysis  
Capturing of data was done using Microsoft Excel spread sheet and analysis was done using the 
Statistical Package for Social Sciences (SPSS) version 23 programme. Each questionnaire was 
checked for its completeness, cleaned before being entered into the Excel spread sheet. After that, 
the data was then exported into the SPSS programme for processing and analysis. Univariate 
descriptive statistics was used to check for accuracy of data by checking out of range values, 






1.10.8 Ethical considerations  
Written informed consent was obtained from all respondents who agreed to participate, after 
obtaining ethical clearance from the Biomedical Research Ethics Committee (BREC). A letter of 
permission was obtained from the Ministry of Health, Maseru, Lesotho to commence the research. 
Ethical principles about privacy and confidentiality of the respondents, informed consent, and 
strict anonymity were observed.  
 1.11 STRUCTURE OF THE DISSERTATION  
This dissertation follows the traditional thesis format comprising five chapters: the Introduction, 
Literature Review, Methodology, Discussions and Conclusions. 
CHAPTER ONE: This chapter offers background information to the study as well as a statement 
of the problem. It also includes the purpose of the study, the conceptual framework as well as the 
rationale and significance of the research.  
 
CHAPTER TWO: This chapter includes a literature review on the research topic. Also, the 
chapter provides information on prior studies to highlight the importance of the research topic. 
Information on the theory associated with adherence will be discussed as well as methodological 
strengths and limitations of some of the research conducted.  
 
CHAPTER THREE: This chapter deals with the methodology including aims and objectives. 
The study adopted the quantitative research approach.  Procedures for data collection, ethical 
issues and a discussion on quality and rigour in the study will be presented.  The study design, data 
collection techniques, sampling and study population together with measuring tools and data 
analysis are also presented in this chapter.   
 
CHAPTER FOUR: The findings from the research will be presented in this chapter. Descriptive 





CHAPTER FIVE:   This chapter focuses on the summary of the discussion, conclusions and 
recommendations of the study. Comments are made regarding limitations, study implications and 
































CHAPTER 2: LITERATURE REVIEW 
2.1 INTRODUCTION 
A literature review is a process that attempts to identify lacuna in information on the subject matter 
been researched. This may serve as a foundation in which new research is undertaken to generate 
new knowledge. A study cannot be conducted in isolation (25). Prior knowledge is needed to carry 
out research.  This chapter elucidates what is in the literature and put the research into perspective 
while providing background information relevant to adherence to antiretroviral therapy among 
people living with HIV and AIDS. The researcher explored previous studies that have been 
published using databases such as PubMed, Google Scholar and Cochrane Library. Literature 
relevant to the study was selected and reviewed. Keywords such as Adherence, ART were used to 
gain a broader understanding of the research. Also, an extensive review of relevant journals, books 
and policy documents was carried out. The results of the searches were helpful in gaining a better 
understanding of the study while substantiating it scientifically. 
2.2 SUB-SAHARAN AFRICAN HIV/AIDS  EPIDEMIC  
It was estimated that 72% of AIDS deaths that occurred worldwide in 2009 occurred in Sub – 
Saharan Africa. The Sub–Saharan African epidemic has thrown up three epidemic patterns with 
proportions of persons living with HIV ranging from 24.9% to 27% in Southern Africa. The 
proportion of people living with HIV in East Africa and West Africa ranges from 3 – 7% and 2 – 
5.3% respectively. In Southern Africa, the prevalence is particularly high in the regions with 
Lesotho recording 23.6%.(2)  The effect of the epidemic continues to manifest in Sub-Saharan 
Africa as it continues to record 2.1 million new infections daily.(26)  It is estimated that out of 35 
million people diagnosed with HIV worldwide, 25 million live in Sub-Saharan Africa.(26) 
Lesotho, a resource-limited setting and one of the countries hardest hit by the epidemic, has made 
unprecedented efforts and remarkable progress since 2004 when it set its ‘3 by 5’ target of putting 
on treatment 50% (28, 000) of the population who need ART by the end of 2005. However, this 
urgency and intensity of effort have met with less success in extending the provision of ART to 
the entire population in need.  By the end of 2006, 17,966 of 57,000 people who needed ART were 




Saharan African region indicated that 77% of clients successfully achieved an optimal level of 
adherence while 23% achieved a sub-optimal level.(27)  
There are not many documented studies of adherence in Lesotho. The few studies that are available 
only talked about the facilitators and barriers to adherence and are mostly qualitative in nature. 
The assessment of adherence to HAART could, therefore, be an opportunity to identify potential 
obstacles to being ART compliant. This may help prevent treatment failure and any resistance to 
medication that will occur as a result of poor adherence. 
2.3 GLOBAL ART COVERAGE 
In 2013, worldwide, there were 1.5 million deaths, 35 million living with HIV and AIDS while 
there are 2.1 million new infections. There has been a remarkable increase in access to ART since 
its introduction. Access to ART has been expanded considerably reaching up to 9.7 million people 
in resource-limited settings in 2012. This represents an increase from 54% to 65% of the 15 million 
target. The UNAIDS report highlighted that ART has the desired effect by reducing new cases of 
HIV infections and also AIDS-related mortality and morbidity. However, the progress made 
masked some disproportionate access to ART. According to (28), eligible men are less likely to be 
receiving ART, which might reverse the gains already made. 
At the end of 2013, an estimated 12.9 people were on ART globally.(26)  The scale-up of 
antiretroviral therapy has seen an increase in the percentage of individuals living with HIV not 
receiving ART from 90% in 2006 to 63% in 2013.(26)  Of the 12.9 million people currently on 
ART, 5.6 million people were put on ART in 2010. It is estimated that the rapid scale-up of ART 
occurred in Sub-Saharan Africa which continues to endure the ravaging effect of the epidemic. 
2.4 OVERVIEW OF THE IMPORTANCE OF ART ADHERENCE 
The progression of HIV to AIDS will eventually result in morbidity unless appropriate ART 
intervention is instituted. The importance of adherence to ART in the successful management of 
HIV cannot be overemphasised. Viral suppression and clinical progression of the disease is 
achieved through adherence to ART. Achieving maximum benefits of ART requires 95% 
compliance in taking the medication as anything short of this, may result in the evolution of 




inability to adhere to antiretroviral treatment has been shown to have a severe impact on 
individuals, families and public health putting pressure on the available resources. 
The ends of AIDS is an aspiration vision. As of today, the key to ending AIDS is epidemic control 
as a result of deliberate intervention measures (CAPRISA, 2016). One of the measures is ART, 
which helps to prolong the life of the people living with HIV. The essence of ART is to achieve 
viral suppression thus minimising weakening of the immune system and enabling it to recover 
from the damage caused by the HIV. The interconnection between adherence and therapeutic 
success cannot be overemphasised, and it has been seen across a broad range of highly active 
antiretroviral therapy (30). According to UNAIDS (28) the following are the main types of ARVs: 
 
 Protease inhibitors (PIs) targeting HIV protein called protease thus it prevents the 
processing of the viral protein into functional components 
 Nucleoside/Nucleotide reverse transcriptase inhibitors (NRTIs) targeting HIV protein 
called reverse transcriptase thus preventing the conversion of viral RNA into DNA 
 Non-nucleoside reverse transcriptase inhibitors (NNRTIs) acting on the HIV protein 
reverse transcriptase but does not require activation. 
 Fusion inhibitors blocking the entry of the virus into the cell. 
 
Successful treatment of people living with HIV and AIDS remains one of the greatest challenges 
in Sub-Saharan Africa. This affects a high volume of people living with HIV in Lesotho. In this 
country, approximately 92,747 PLWHA were receiving ART while a further 170,000 were yet to 
be linked to care. It is imperative that, for the country to be able to achieve the 90-90-90 target, 
factors that determine the success of ART need to be explored. Adherence to ART will play a 
significant role in ensuring that HIV no longer represents a public health threat through a reduction 
in the level of infection and no longer represent one of the country’s highest disease burdens. This 




The advent of HAART marked a breakthrough in the fight against the human immunodeficiency 
virus (HIV). However, this breakthrough was not without its challenges. HIV infection has become 
a chronic infection due to adherence, unlike the previous years, whereby HIV infection was 
associated with fatal and debilitating outcome. PLWHA placed on ART can enjoy relatively 
normal lives. Increasing access to ART in Africa which accounts for 68% of the global population 
of PLWHA (28) has led to prolonging and healthy lives among HIV-positive people. The public 
health burden of HIV is still very much palpable in Sub-Saharan Africa. There is still high 
mortality due to HIV. In 2010, of the 1.8 million deaths attributable to the epidemic, 1.2 million 
of them were reported in from the Sub-Saharan Africa. 
Much as the end of AIDS is an aspirational vision, the golden rule of thumb for the treatment of 
infected individuals is ART. ART plays a role in prolonging and improving the quality of lives of 
the PLWHA. PLWHA are linked to care through HIV continuum. ART is prescribed and consists 
of daily dosing. The essence of ART is to suppress the viral load and to increase the CD4 counts. 
It thus minimises the weakening of the immune system. The benefits of ART in the management 
of HIV are well established in some settings. (31) 
2.5 ADHERENCE TO ANTIRETROVIRAL THERAPY  
Adherence to antiretroviral therapy (9) is pivotal to the management of HIV. It seeks to maximise 
good health outcomes while minimising the attendant risk of developing viral resistance leading 
to increasing morbidity and mortality. Adherence to ART has resulted in therapeutic success across 
a broad range of highly active antiretroviral therapy regimens (HAART) such as protease 
inhibitors, nucleoside reverse transcriptase inhibitors, and non-nucleoside reverse transcriptase 
inhibitors. HAART has been shown to be highly effective in the suppression of plasma HIV -1 
RNA, improving CD4 cell counts that ultimately lead to decreased morbidity and mortality of 
HIV-infected patients. Studies conducted in different settings have established the benefit of 
HAART in the management of HIV.(31-33) 
However, successful treatment outcomes were dependent on the patients’ ability to adhere to ART, 
which may be influenced by factors both within and outside the clinical environment. For HAART 




developing viral resistance due to rapid replication mutation of HIV. Some studies conducted, 
however, reported success in viral load with less than 95% adherence.(34, 35) 
Immunological and virological failures can arise as a result of poor adherence to medication 
leading to resistant strains of the HIV. Drug-resistant HIV is a public health concern as it not only 
add to the cost of health care to the individuals and the community, it contributes to higher 
hospitalisation rates and decimation of the workforce. The loss of productivity of the workforce is 
of concern to any country because they are the driving force of the economy. In resource-limited 
settings such as Lesotho, which do not have the wherewithal to monitor drug resistance and often, 
not enough capacity to provide second line regimen, this is of concern.(36)   
Different studies conducted on adherence in Sub-Saharan Africa have been promising. A meta-
analysis review estimated adherence to be in the region of 77% in African settings. This was in 
comparison to just 55% adherence in North American settings (adherence is usually measured by 
taking 95% of the pill prescribed) (27, 37). In addition to the above, studies conducted in some 
African countries such as Botswana, Tanzania, and Uganda have reported a high level of adherence 
to the prescribed medication and showing positive outcomes of ART.(27, 38) 
2.5.1 Measuring adherence 
Measuring adherence to ART has raised so many questions.  This is because of lack of definitive 
accepted ways of adherence measurement. Across all illness, commitment to taking medication 
involves the individual, sets of complex and dynamic behaviour that present difficulty in 
measurement. It is imperative that measurement of adherence to ART be accurate in evaluating 
interventions aimed at improving adherence. Measuring patients’ adherence to antiretroviral 
therapy is further complicated by the different diversity of measures available, depending on the 
clinical and research settings the study is carried out. (39, 40) 
Various methods have been used to detect the extent of patients compliance to taking medication. 
Such measures of adherence vary from electronic drug monitoring to pharmacy refill records. 
Other methods used is self-report, pill counts and plasma concentration of the drug and its 






Most commonly used form of adherence measurement in the clinical setting where clients are 
asked to recall doses missed in the past few days. It is not expensive, flexible and requires little 
time to complete. Discussion about missed doses and possible solutions could be done in clinical 
settings with this type of method. 
In a systematic review utilising different self-reported means of antiretroviral therapy (9) adherence 
measurement, it was found that there was a correlation between the HIV viral load and self- 
reported adherence in 84% of recall periods. In 65% of studies conducted using meta-analysis, the 
odds that the viral load will be detected was twice in non-adherent patients compared to the patients 
that adhere. (43, 44)  Similar studies done in India reported adherence to be at 74%. (37)  
Several limitations of the self-reporting methods have been documented. These ranged from non-
standardized questions, over-reliance on the recall of events most likely forgotten and its 
vulnerability to social desirability in patients’ reporting. Patients often over-estimate their 
adherence and only tend to remember short-term events. Research conducted in Uganda on 
adherence using self-report had the same high preponderance as with the objective measure of 
monitoring medication through electronic means. Self-report might be beneficial in resource-
limited settings. (30, 39, 40, 42) 
2.5.1.2 Pill counts 
Pill counts have been widely used in clinical settings, and it involves counting the leftover 
medications in the client’s bottle or vials. Patients are expected to bring their pill containers to the 
clinic for the pill count to be conducted. Excess pills found in the container give an indication of 
adherence or non-adherence. However, there are many shortcomings associated with this type of 
method. Patients may deliberately throw away their pills before their visits to the clinic giving the 
impression of adherence. Thus, adherence may be over-estimated.  Other shortcomings noticed 
with pill counting was that it did not provide information on the time the dose is taken and doses 
taken during the holidays. It is essential that these be taken into consideration as they are important 
in determining the success of treatment.  Another downside to pill counting is the issue of trust as 




Dumping of the pill may be minimised in unannounced pill counts in research settings and have 
been documented to be slightly more effective in predicting the viral load than the electronic drug 
monitoring. (35) 
2.5.1.3 Electronic drug monitoring 
Electronic drug monitoring (EDM) has been utilised in measuring adherence in chronic diseases. 
HIV researchers have frequently used electronic drug monitoring. The method makes use of 
surveillance device embedded with a microprocessor. This electronic device record the time and 
date each bottle is opened. Information is stored in the cap until it is downloaded  (45, 46). 
In a study conducted in China using electronic drug monitor feedback, the mean adherence among 
Chinese ART patients improved significantly. (47)  However, the study could not determine any 
effect on the degree of viral suppression and also, there is a lack of script for the EDM feedback 
counselling.(47)  Given this, further research might be necessary to understand how EDM feedback 
altered the style and content of counselling sessions. 
Electronic drug monitoring is not without limitations. Underestimation of adherence may occur as 
a result of inconsistent use of the cap and the “pocket dosing effect”, a situation where the patient 
removes more than one dose with a view of taking the extra dose at a later time. Other potential 
limitation could be as a result of patients opening the bottle without removing any pill otherwise 
known as “curiosity opening”. Thus, electronic drug monitoring (EDM) has the potential of 
overestimating adherence  (45, 48). 
2.5.1.4 Pharmacy Refills records 
In a closed pharmacy system, pharmacy refill records can be used to assess adherence in areas 
where medication are dispensed over a period, and financing is done in a particular place. These 
are measured at several points in time. This method can provide the research scientist or the 
clinician with information on the number of occasions prescription are handed out, and that can be 
used to determine the extent of patients adherence to the prescribed medication or not.(41) 
This method is premised on whether patients receive timely refills from the pharmacy, as measured 




actual refill dates is used to determine the adherence rate of the patient.(49)  The disadvantage of 
this method is its over-reliance on the assumption that patients who get their supply regularly do 
comply with medication adherence. The assumption that patients that get timely refills comply 
with adherence has been subjected to validity test by comparing the association between adherence 
to pharmacy refills and clinical outcome. Several studies have indeed shown a correlation between 
viral loads and medication refills (42).   A study conducted in Australia, comparing the long-term 
adherence to ART using self-reports and pharmacy refill records found out the correlation between 
pharmacy refills files and self-reports. It recorded <95% level of adherence as non-adherence for 
pharmacy refills records and <97% as non-adherent for self-reports.   
2.5.1.5 Therapeutic drug monitoring 
A Therapeutic Drug intervention can be monitored in vivo as a direct consequence of measuring 
adherence to medication and is widely known in a scientific environment. The insufficient 
concentration of drugs in the body are some of the reasons for treatment failures in PLWHA. This 
may not be unconnected to poor adherence.(41)  The low concentration of drug in the body has been 
responsible for non-adherence and viral failure. A cross-sectional study of 83 individuals to 
explore the association between drug concentration in the body system and adherence to 
medication, found out 88% low drug specificity for detecting adherence.    
The expensive nature of therapeutic drug monitoring makes it difficult to use across various 
settings. One of the major drawbacks is the timing of the medications which may affect its plasma 
concentration. Thus patients may become compliant in anticipation of the test as its reflects 
adherence over 24 hours (42). 
2.6 Factors affecting adherence 
It is imperative to identify predictors of adherence before measures to improve them are put in 
place.(13)  Many factors have been attributed to contributing to non-adherence. Factors including 
behavioural, provider related (or health systems) and socio-demographic have all been implicated 
in contributing to non-adherence to ART. Predictors of adherence that have been identified in the 
literature could either impact positively or negatively on the patient's’ adherence. Such factors 




treatment benefit, knowledge about illness and the medication, the complexity of therapy, 
education attainment and disease progression. 
Factors affecting adherence are commonly arranged into disease characteristics, individual factors, 
treatment regimen, interpersonal relationships such as doctor-patient relationship, and the 
medication factors that have to do with the complexity of the treatment regimen. However, it is 
important to note that,  interrelationships exist among those factors.(50) Ammassari(51) Wang(4) 
established that the reasons adduced for missing doses are the complexity of the regimen (7%-
52%) and side effects (13-42%). Other factors include patients forgetting to take their medications 
(30-66%), disclosure worries (14-33%), and the inability of the patient’s to integrate treatment 
regimen into their daily schedule.(51)  A study done in Zambia on adherence to ART came up with 
three main factors affecting adherence: 
 Socio-economic and cultural factors 
 The patient’s beliefs and behaviour such as busy work schedule, excessive alcohol 
consumption, experiencing better health. 
 Service provider-related (health system) factors such as lack of appropriate counselling, 
privacy and confidentiality, distance to the health facilities, time constraints during the 
consultation and lack of effective communication between the clients and the service 
providers. 
Adherence to ART has been associated with improved clinical outcomes by increasing the CD4 
count in due course and lowering the viral load at initiation.  Mannheimer(52) found out that 
improvement in the quality of life is seen over time in clients that successfully maintained 80% 
adherence whereas (53) found no association between quality of life and adherence. The adverse 
effect of ART has been found to contribute to non-adherence in 50% of cases.(53)  Factors such as 
depression, poor social support, provider relations and attitudes, such as mistrust about treatment 
and medication have been consistently associated with poor adherence.(53) 
Other predictors of adherence to ART identified are the level of education and age. Factors such 
as forgetfulness and complexity of the regimen have also been implicated as some of the factors 
preventing adherence to ART. Low literacy levels have also been implicated.(54)  A systematic 




with dosing during work time, depression, coupled with negative thoughts, was found to be 
implicated factors in such group of people.(55) Negative characteristics of particular medication 
regimens are common barriers to adherence. Adverse reactions to ART will most likely result in 
discontinuation of the said medication. Diarrhoea, hallucinations and vomiting have been reported 
as one of the transient adverse effects of HAART while fat redistribution otherwise known as 
‘Buffalo hunk’ and peripheral neuropathy are some of the longer lasting side effects. 
2.7 THEORETICAL FRAMEWORK 
Behavioural interventions are theories that attempt to change the behaviour of the individual or to 
develop good health (56). Researchers have sought to modify behaviour to achieve the desired 
outcome. Behavioural intervention has become increasingly popular among researcher to 
understand adherence to medication. The essence of the theoretical framework guiding this 
research is geared towards understanding how PLWHA, on ART rationalise threats to their well-
being, rationalising solutions to the threat while in fact, the solutions may or may not be carried 
out. Several theories have been proposed in understanding and modifying health behaviour. The 
focus of this study is the cognitive aspect of health behaviour and the framework adapted from the 
Health Belief Model.(56) 
The Health Belief Model (HBM) has explained variation in adherence to chronic medication. An 
important component of the HBM is beliefs about medicines, and it has been postulated by various 
researchers that it is an important influencing factor in the behavioural use of medication.(56) The 
model discussed four major critical elements which influence patients’ adherence to drugs: (Figure 
2.1) 
 Belief about the seriousness of the disease (perceived severity) 
 The risk of illness (perceived susceptibility) 
 Outcome expectations (perceived Benefits 





 Perceived Seriousness: This deals with the individual's conviction as regard a medical 
condition. This is usually informed by the knowledge or information acquired about the 
disease. Perceived severity may also arise from the belief that the disease may cause some 
difficulties that will be difficult to overcome. Individual perception of the seriousness of a 
disease differs. A self-employed man might perceive flu as severe because of loss in wages 
while a government employee may not. The threat of contracting HIV and consequence of 
its manifestation such as rashes, hospitalisation, wasting away and death are some of the 
perceived threat to the individual.(57)  
 Perceived susceptibility: Individual perception of risk of contracting a disease will elicit 
a preventive action. This will motivate people to adopt a healthier behaviour. It is assumed 
that the greater the risk, the more likely it will elicit a reaction to decrease the risk. Thus, 
it is only normal that individuals at risk of contracting an infection or disease do something 
to stop it from happening. Therefore if people living with HIV and AIDS believe they are 
at the risk of progressing to full-blown AIDS when they do not comply with their treatment, 
this will motivate their adherence to their medication likewise if there is no perception of 
susceptibility.(57)  Their susceptibility is influenced by factors such as education, inability 
to negotiate condom use, distance to the clinic and economic factors. 
 Perceived Benefits: This construct relies on the individual’s opinion of the importance of 
new behaviour in ameliorating a particular disease from developing. It is believed that 
people adopt a healthy behaviour when they feel it is beneficial to their overall health. The 
question is would PLWHA adhere to their medication if they perceived it to be beneficial? 
Thus it is imperative that adoption of secondary preventive behaviour is believed to be 
advantageous to the individual such as adherence. Studies have consistently shown that 
individual beliefs influence adherence to medication, thus any doubts as regard the need 
for that medication is associated with low adherence.(58)  It can be assumed that belief in 
medication influences its use, whether positive or negative. Medication outcome 
conceptualises its use by patients to achieve a specific health need. In this study, the 
assumed benefits of taking ART medication can be seen as a necessity to suppress HIV 
 Perceived Barriers: Behavioural change does not come easily unless the positives 
outweigh the negatives. The individual need to analyse the obstacles preventing him from 




adopting a new behaviour serves as a motivation for embracing a healthy behaviour. People 
living with HIV and AIDS might perceive the side effects of the medication as a barrier to 
continuing with its use. The moment they can convince themselves of its benefits as 
outweighing its negatives, it will be easier for them to maintain adherence. 
 













Figure 2. 1 Theoretical framework adapted from the Health Belief Model(9) 
 
The model takes cognisance of other factors that could shape the health behaviour of an 
individual. Predisposing factors such as beliefs, values, attitudes and enabling factors such 
as availability of drugs and access to the health care facility are some of these factors. 
Another consideration in the model is the reinforcing factors like feedback, assurances from 
the healthcare provider and peer support groups. Knowledge, attitude and individual 
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practices are thought to drive perceived susceptibility to a disease.(20) The use of medication 
and the experience from such use will influence the behaviour towards such medication (9). 
The patients experience of adverse drug reactions is due to the adverse events occurring 
which the patient might have attributed to the ARVs. This ultimately shapes the behaviour 
of the patient towards the ARVs. Subsequent use of such drugs by the patient may be 
influenced by the possibility of adverse effects of the drugs (9). 
Predicting adherence to medication is a very complex issue as it involves interrelationship 
of so many factors. Knowledge about health and personal beliefs might not be sufficient to 
initiate change in behaviour especially in a situation where long-term adherence is required 
as in the case of HIV and AIDS. It is essential to understand how PLWHA evaluate and 
interpret their situations as well as having the belief and motivation to adhere to treatment. 
Thus health care practitioners have a role to play in assisting patients accepting and 
implementing healthy behaviour, reduce barriers and threats.  
2.8 CONCLUSION 
One of the biggest challenges facing the scale up antiretroviral therapy is adherence. ART is 
a life-saving medication only if patients adhere to the course of treatment. Different health 
theories have attempted to improve our understanding of adherence to chronic medication 
and how they can be used to achieve adherence. This research explores the predictors of 
adherence to ART and makes a recommendation for intervention where possible. The 
literature review delves into factors affecting adherence and the different methods of 
measuring adherence. Also, the HBM model was explored to gain an understanding of 









 CHAPTER 3: RESEARCH METHODOLOGY 
3.1 INTRODUCTION 
The previous chapter discussed the literature relevant to adherence to ART, measures of adherence, 
factors influencing adherence to ART and the theoretical framework applied in carrying out the 
research. This chapter presents the research methodology employed by the researcher used in 
determining the predictors of adherence to ART in Quthing Hospital and Villa Maria Health 
Centre. The research methodology employed was influenced by the research objectives. This 
chapter includes the aims and objectives, the research design and the study population. Also, the 
sampling procedures, the research instruments, data collection tools, validity and reliability of the 
research instruments were discussed. The least but not the last, data analysis and ethical 
considerations related to the study are presented.  
3.2 AIMS AND OBJECTIVES 
 The aim of this study is to determine the level of adherence to ART and to document the factors 
associated with antiretroviral therapy adherence in Quthing District, Lesotho. 
The study attempted to answer the following objectives: 
 To establish the proportions of patients that adhere to antiretroviral therapy received from 
Quthing District Hospital and Villa Maria Health Centre in Lesotho. 
 To determine factors influencing adherence to antiretroviral therapy received from Quthing 
District Hospital and Villa Maria Health Centre in Lesotho among PLWHA. 
 To determine the knowledge of HIV and practice of ARVs among PLWHA in Quthing 
District Hospital and Villa Maria Health Centre in Lesotho 
3.3 RESEARCH DESIGN 
Research design attempts at explaining the strategies and methods that were used in conducting 
and obtaining data as regard the phenomenon of interest. Also, it gives a clear indication of the 




and Painter(60), the choice of method to be adopted in research is primarily influenced by the ability 
to control factors that could alter the reliability and validity of such research. Research design 
serves as the backbone of the study in which answers are obtained to the phenomena being studied.  
3.3.1 Study design 
Quantitative research approach has often been regarded as the traditional scientific method to 
research. This approach derived its root from the philosophical paradigm for human enquiry 
otherwise called positivism. Essentially, it uses mathematically based methods to explain 
phenomena after subjecting the data collected to statistical calculations to obtain  quantifiable 
information. (61)  A positivist approach to research emphasises objectivity with rational thoughts, 
Prediction and control. (62) Researchers are of the opinion that quantitative research is less 
susceptible to bias. This view is rooted in the belief that orderly and disciplined procedure 
characterised the objective form of measurement in the social world.(63)  
In this study, cross-sectional analytic design was used. A research design allows the researcher to 
plan the nature of the research to be undertaken.(22)  This method is sometimes used to investigate 
the association between risk factors and outcome of interest.(22) The limitation of the design stem 
from the fact that it does not measure sequence of events regarding whether exposure occurred 
before or after as it is usually carried out at a point in time. Thus it  is hard to infer causality. The 
design was chosen because it allows the research to be conducted at a point in time, over a short 
period. Cross-sectional design is usually used to estimate the prevalence of outcome in the 
population of interest, usually to plan public health programmes or intervention. 
Data on individual information as well as exposure to the risk factors and outcomes are collected 
and measured. This enable the risk factor to be investigated while offering a snapshot of the 
outcome interest coupled with the characteristics associated with it at a particular point in time. 
This design will offer insight regarding the relationship and strength of the associations among the 
variables under investigation which is predictors of adherence to ART. Issues relating to adherence 
to ART among PLWHA had been highlighted by the researcher. The Predictors of adherence to 




is the problem been studied. The above design was chosen because fewer resources and time are 
needed for the investigation to be carried out. 
Some researchers have stated that some public health issues are better studied using quantitative 
approach while others are better suited using qualitative.(18) Whatever methodologies employed, 
health research methodology needed to be diverse and picked to suit the problem under 
investigation. The variables under survey in this study include education level, Alcohol 
consumption, ART perception that is quantifiable. Thus objective and epistemological stance as 
regard the study variables was adapted. Descriptive and inferential statistics are employed. A 
cross-sectional study is a form of quantitative design in which data are collected at a specific point 
in time or extended over a period. A non-experimental cross-sectional design was used in this 
study. 
3.3.2 Study population and study area 
 The study population was drawn from Quthing District comprising of males and females, aged 18 
years or older, and were on ART for more than three months. Quthing District Hospital and Villa 
Maria Health Centre were selected because they were one of the pioneering sites of ART and the 
population groups can be found in the district representing a heterogeneous population. According 
to the records, there were 5,000 adult patients 18 years or older on ART in the two facilities 
chosen.(24)   
3.3.3 Power of the Study 
The ability of a research study to demonstrate an association between two variables of study is the 
power of the survey. In a quantitative study, it is desirable always to enumerate the study power 
and to determine the size of the sample required to realise this power during the planning stage of 
the survey otherwise one will end up with a study without statistical power. Researchers 
traditionally viewed a study with a statistical power of 80% to be the minimum.(64) and in this light, 





3.3.4 Sampling and Sample Size 
The choice of a sampling method for this study was simple random sampling to ensure that all the 
study population were given equal chance of being selected using the inclusion criteria which are 
(𝑎) 𝐴𝑑𝑢𝑙𝑡𝑠 (18 𝑦𝑒𝑎𝑟𝑠 𝑎𝑛𝑑 𝑎𝑏𝑜𝑣𝑒), (𝑏) 𝑏𝑒𝑒𝑛 𝑜𝑛 𝐴𝑅𝑉 𝑡𝑟𝑒𝑎𝑡𝑚𝑒𝑛𝑡 𝑓𝑜𝑟 𝑡ℎ𝑟𝑒𝑒 𝑚𝑜𝑛𝑡ℎ𝑠 𝑜𝑟 𝑚𝑜𝑟𝑒. 𝑇ℎ𝑒 
exclusion criteria were (a) Patients below the age of 18 years. (b) On ART for less than 3 months. 
(c)  Patients initiated from a different clinic or hospital from the study centre. (d)  Pregnant women 
because they are on different ART regimen and attend clinic away from the ART clinic. The file 
number of all the 5,000 patients was listed. Participants were selected from the random number 
generator until the desired sample size of 382 was attained. If a participant selected was ineligible 
or refused to participate, the lot fell on the next person on the list. The calculation of the sample 
size was done using a single population proportion formula with a 0.05 margin of error and 50% 
proportion of the event occurring. 
The sample size was determined using the following formula: 
n = N 𝑛 = 𝑁 × 𝑋/(𝑋 + 𝑁 − 1) 
Where 𝑋 = 𝑍𝛼/22× 𝑝 × (1 − 𝑝)/𝑀𝑂𝐸2   and Zα/2 is the critical value of the normal distribution 
α∕2. For this study the confidence level was 95%, α was 0.05 and the, critical value was 1.96. MOE 
was the margin of error while p is the sample proportion, and N was the population size. The above 
assumption generated a sample size of 382 for the study. 
3.3.5 Data collection 
The researcher used questionnaire-assisted interview to collect data over a period of three months 
from April 2016 to June 2016 among ART clients attending clinic in the study setting. Participants 
were recruited consecutively over the study period until the desired sample was obtained. 
Questionnaires are a group of structured questions or questions arranged in sequence to extract 
information from a respondent or participant that can be completed by the participant or the 
interviewer through questions been asked. (22)  The questionnaires were administered by two 
research assistants who were recruited and trained. They were registered professional nurse having 
more than seven years working at ART clinic. Their work includes HIV counselling and testing, 




and other opportunistic infections related to HIV and AIDS, strengthening engagement in care and 
retention in care by developing plans to ensure adherence. Both research nurses speak English and 
Sesotho fluently and as at the time of the study, they were not engaged in the ART clinic where 
the study was carried out. 
Training was offered to the research assistants to enhance their skills in protecting human 
participants in research. Role play was used in training the assistants to ensure consistency, in 
obtaining informed consent, completing questionnaires, how to handle questions and approach in 
the administration of questionnaires. Simulation of the process was done by each of the assistant 
using a volunteer to explain the study process to would - be participants. The simulation was also 
done on how informed consent will be obtained and handling queries that may arise in the course 
of the research from the participants. The research assistants were told to liaise with the principal 
investigator in resolving critical issues. The questionnaires were both in English and Sesotho.  
Patients who are on ART accessing services from the study settings were duly informed about the 
research. Since they were all potential participants, explanation on the risk, time, benefits and 
eligibility were explained to them. Respondents selected were further educated on their 
commitment and informed consent obtained from them. After that, questionnaires were then 
completed by the participants through assisted interview by the researcher and the assistant. The 
questionnaires were completed at the convenience of the participants while ensuring privacy at all 
times. The completion rate of each questionnaire by the participants on the average was 40 -55 
minutes. Incentives were not offered to the participants in order not to compromise the standard of 
the research and exert undue influence. The recruitment of participants was solely voluntary. 
3.3.6 Research instruments and variables measured 
Questionnaires have the advantage of been less costly, provide anonymity of the interviewees, 
eliminate  interview bias, and  are easy to use. Also, the data generated from the questionnaire can 
be easily analysed.(22) 
 The questionnaire was developed using the literature review as terms of reference and in line with 
the research objectives. It consisted of five sections. The questionnaire consisted of socio-




following were captured in the demographic information; gender, age, marital status, educational 
level, religion, place of residence amongst others.  Other data included in the questionnaire were 
the information on ART regimen, number of years on ART adherence, knowledge of HIV and 
AIDS. Data on HIV disclosure to the sexual partner and sexual behaviour were collected among 
the sexually active participants. Sexually active participants were presumed to have at least one 
sexual encounter with a partner in the course of three months preceding the study.(65) 
The level of adherence in the study was quantified using three measurements tools, and these are 
(a) self-reporting of any dose missed. The participants were interviewed for missed doses for the 
past four days and if no doses were missed during the previous four days. (b) The number times 
the participants renewed his or her prescription expressed as the number of times the participants 
come for their appointment in the last three months preceding the study. Participants that do not 
miss any appointment were presumed to be adherent. (C) By counting the number of pills 
remaining. The research assistant records the number of pills remaining. Adherence is calculated 
using the number of remaining tablets and missed tablets or medication absorbed. ART patients 
are expected to renew their medication every month by appointment, usually at their respective 
ART clinics. Participants were considered adherent with a percentage intake of pills equal to or 
greater than 95%. 
The result of all the different measurements of adherence was summed up to obtain the global 
index of adherence by assigning a coefficient to each item with 1 for adherence and 0 for non-
adherence. In essence, the participants were categorised into two using the global index of 
adherence to ART. Thus poor adherence index from 0- 1 while good adherence index ranges from 
2 to 3.  
3.3.7 Pre-test/Pilot study 
This is a study undertaken before a planned project specifically to test research instruments 
developed for the research is called pilot study. This is to enable the researcher to identify any 
flaws and make the necessary adjustment before the final preparation of the design.(61) The tools 
were tested in the health facility and the hospital on a total of 25 patients with similar 
characteristics to the sample that was selected. This is to enable the researcher to address any 




clarity, consistency of the research tool. They were also requested to comment on whether the 
questions were fully comprehended and the time taken to complete the questionnaires. No 
respondent experience difficulty in completing the questions and on the average, participants were 
able to finish the survey between 30 -60 minutes. 
Respondents were able to make some comments which were considered by the researcher. On one 
of the socio-demographic questions concerning age, participants felt that above 35 years old was 
too ambiguous. They advised it should be broken down further. This prompted the question to be 
broken down to 35 – 45 and the researcher included more than 45 years. Furthermore, the 
participants in the pilots study observed that there were no filters that might influence adherence 
to ART. This set of questions was then added. The questionnaires were then revised based on the 
feedback from the pilot study participants which assisted in the training of research assistants on 
how to administer the questionnaires. 
3.4 DATA CAPTURING AND ANALYSIS 
Data entry was done using Microsoft Excel spread sheet and analysis were done using the 
Statistical Package for Social Sciences (SPSS Inc.) version 23.0 manufactured by IBM (Chicago, 
IL, USA) after it has been entered and captured into MS Excel spread sheet. The researcher 
checked each questionnaire for completion to ensure that they were answered correctly before 
being entered into the MS Excel spread sheet. Each questionnaire was checked for errors, cleaned 
and then exported into the SPSS programme for processing and analysis. Data was double checked, 
and each of the variables was separately examined using the SPPS for entry accuracy and missing 
values. They were also checked for fit between their distribution and multivariate analysis 
assumption. Strange data was checked for values out of range, means and standard deviation using 
univariate descriptive analysis to confirm the accuracy of data.  Twenty-one questions were 
included in the questionnaire which included five sections namely: socio-demographic 
characteristics, clinical features, knowledge of HIV and AIDS, barrier to adherence and adherence 
to antiretroviral therapy.   
Adherence to ART is the dependent variable assumed by the researcher to be influenced by the 
independent variables such as the socio-demographic data, ART perception, knowledge of HIV 




variables include religion, place of residence, duration of therapy, clinical WHO stage, any 
reported side effect, HIV status disclosure, duration of treatment and barriers to adherence. 
Descriptive statistics was used to summarise the demographic data. This includes means, 
frequency distribution and percentages were used while proportions were used in calculating the 
categorical variables. The primary interest in the research is to compare People living with HIV, 
who were adherent compared to those who were not adherent. The bivariate associations between 
the variables were assessed using Pearson correlation and Fischer’s test employed where 
appropriate. Multivariate logistic regression analysis was used in determining predictors of 
adherence. Logistic regression was utilised for all variables that are significant at a p-value less 
than 0.05 during bivariate analysis. The confidence interval used throughout was 95%. The 
variance observed was used.  
3.5 INTERNAL AND EXTERNAL VALIDITY OF THE STUDY 
Internal validity could be defined as the degree to which inference can be made from causal 
conclusion from a study between the independent variable and dependent variable and the ability 
to generalise or extrapolate the study findings beyond the area of study to other settings.(66)   The 
independent variables were age, sex, educational level, marital status, duration of ART therapy, 
type of ART prescribed, and the therapeutic line while the dependent variable was adherence. 
Cross-sectional designs limit the degree to causal inferences, and generalisation that can be made 
in a study. The use of fairly large sample for the study and the sampling method used to enhance 
the external validity of the research.  
3.6 CONTENT VALIDITY OF THE RESEARCH INSTRUMENTS 
The degree to which intended domain of content is reflected in measurement is known as content 
validity.(67)  The researcher undertook the following measures to ensure that all the facets of the 
constructs under investigation were logically presented; 
 The consistent refinement of the construct under investigation 
 Target population were  consulted to increase the content validity of the item 




 Extensive consultation of the literature relevant to the constructs under investigation so 
(68)that the characteristics of the domains can be defined such as the variables being 
investigated. 
3.7 RELIABILITY OF RESEARCH INSTRUMENTS 
Summated scales often probe the underlying constructs of interest in research. Responses to a 
dichotomous questionnaire or are indexed and analysed to arrive at a score for the individual 
participants.   In essence, the consistency and accuracy at which an instrument measures the target 
attribute are defined as reliability.(18)  It is essential that the reliability of the summated scales be 
known since they are designed to measure underlying constructs. The power of the study is 
strengthened by the reliability of the instruments to identify the relationship of any significance in 
a population of study. The correlation coefficient is used to express reliability, and they are usually 
in degrees. A correlation coefficient of 1.00 indicates perfect reliability while 0.00 means no 
reliability. The lowest acceptable value for any psychosocial measurement instrument is a 
coefficient of 0.80 while 0.70 coefficient is acceptable for the newly developed instrument. 
3.8 ETHICAL CONSIDERATIONS 
Ethics in research studies are an aggregation of values, behavioural expectations and standard 
principles that shaped the process as regard what is acceptable towards study participants and other 
vested interest in the research world. (22) It is imperative that ethical standards be adhered to at all 
times in the course of conducting research including justice and respect for human rights. In 
conducting this research, ethical considerations included: 
3.8.1 Ethical permission 
Approval was obtained from the Biomedical Research Ethics Committee (BREC) of the University 
of KwaZulu-Natal, Durban, South Africa (Annexure A). Also, approval and permission were 
sought and obtained from the Ministry of Health, Maseru, Lesotho, to conduct the study in Quthing 





3.8.2 Informed consent 
It is essential that informed consent be obtained from human participants before the 
commencement of any research. It involves outlining the idea, values and what the research entails 
to the prospective participants by the researcher. It is important that participants were made aware 
of the nature and the research topic. The purpose of the study, the potential risks and benefits and 
the information that would be collected are made known to the participants (Annexure E). This 
process offers the participants opportunity to have their questions and concerns addressed. The 
consent form was signed by all the participants which allowed them to participate in the study. 
Voluntary consent was obtained from all the participants, and they were informed of their rights 
to withdraw from the study without any repercussions and that, it will also not affect their treatment 
in the clinics. 
3.8.3 Confidentiality 
The participants were assured that information collected in the process of collecting data would be 
treated with utmost respect and privacy. The research assistants used for the study were also trained 
to maintain the confidentiality of all information regarding the respondents. The research assistants 
signed a confidentiality agreement regarding the research. Also, all data were stored in a secure 
location, and access to them was restricted while electronic data were password protected. 
3.8.4 Anonymity 
The questionnaire did not have any personal identifiers and addresses of the participants. No 
identification numbers were used for any of the questionnaires that link the participants to the 
questionnaires neither were they identified in any results published. 
3.8.5 The principle of justice 
3.8.5.1 Right to fair treatment and privacy 
The research team was fair to all the participants, and equal treatment was meted out to them. The 
principal investigator and the research assistants were courteous towards the participants and 




arranged at a time that was convenient to each of the participants and it was conducted in private 
to ensure that their right to privacy was not violated. 
3.8.6 Principle of Beneficence 
3.8.6.1 Freedom from harm 
The research team ensured that the participants were protected from any potential risk even though 
no risk was anticipated. The research was conducted in a safe environment, and the research 
assistants were trained to handle any distressing issues. The research assistants were to report any 
adverse issues promptly to the principal investigator and to discontinue the interview process. All 
the participants were given the assurances that they will not be exploited for any financial or 
personal gain. 
3.8.6.2 Benefit from the research 
The principal investigator informed all the participants that no monetary gain will be received from 
participating in this study. However, their participation will go a long way in contributing to the 
pool of knowledge already known in the field of HIV and AIDS. 
3.8.7 Principle of respect for human dignity 
3.8.7.1 The right to self-determination 
Written informed consent was obtained from all the participants before their participation in the 
study without coercion or intimidation. They were informed of their rights of refusal to participate 
in the study and not to answer any questions they were not comfortable with in answering. 
3.8.7.2 The right to full disclosure 
The management of the hospital and the participants were duly informed about the research. The 
District Medical Officer served as the gatekeeper in ensuring that the research meets ethical 
standards. The names and phone numbers of the researcher and his supervisor were provided in 





3.8.7.3 The right of vulnerable subjects 
The group of participants that participated in the study were considered to be vulnerable due mostly 
to societal attitude towards them. The principal investigator and the research assistants ensured 
that participants were treated with dignity and respect and were not subjected to any form of 
discrimination, stigma and psychological trauma. The interaction between the research team and 
the participants were cordial and non-judgemental. Counselling services and follow-up were 
offered to any of the participants who developed psychological trauma as a result of their 
participation in the study. 
3.9 CONCLUSION 
The research methodology and the design was described in this chapter. The researcher justified 
why the method was chosen and statistical method applied in analysing the data collected. The 
quantitative research instruments, the pilot study and ethical considerations were discussed. This 
chapter also discussed measures taken to ensure that ethical standards are observed at all times. 














CHAPTER 4: RESULTS 
4.1 Introduction 
The researcher has discussed a detailed description of the research design, research methods, 
measures to ensure trustworthiness and ethical considerations in Chapter 3.  This chapter presents 
the results of the participants’ responses to the predictors of adherence to ART among people 
living with HIV and AIDS.  It contains both the descriptive and analytical elements of the research.  
4.2 SOCIO-DEMORGRAPHIC CHARACTERISTICS OF THE STUDY POPULATION 
 The socio-demographic characteristics of the study population are presented in Table 4.1. Three 
hundred and eighty-two participants took part in the study, of which 139 (36.4%) were male, and 
243 (63.6%) were females. The majority of the respondents 199 (52.1%) were above 45 years of 
age while 109 of them (28.5%) were in the 35 to 45 years age group. The majority of the 
participants were clustered between 35 to over 45 years of age, 308 (80.6%). A large proportion 
has been married 326 (85.3%). Of these, 156 (40.8%) indicated that they are still married while 
127 (33.2%) and 43 (11.3%) are widowed and divorced respectively (Table 4.1).  Among the 382 
PLWHA, 156 (40.8%) were cohabitating, and 343 (89.8%) had one form of education or the other. 
The majority of the participants lived in urban areas 296 (77.5%). Though in this study, there was 
a statistically linear relationship between ART adherence and education, there was significant level 
of association (p<0.000). The majority of the participants 212 (55.5%) had primary school 
education while 39 participants (10.2%) indicated no form of formal education. About 104 (27.2%) 
and 27 (7.1%) had undergone a high school education and tertiary education respectively (Figure 
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Figure 4. 1 Educational level of the respondents 
 
 
4.3 HIV AND ART RELATED FACTORS 
The variables measured included the duration of therapy, HIV status disclosure of the respondents, 
type of ART prescribed, barriers to adherence and adherence to ART. On the clinical and 
therapeutic level, the majority of the participants were at WHO clinical stage I (88.5%) while 37 
(9.7%) were at WHO clinical stage II. The remaining seven respondents (1.8%) were at stage III 
and IV. The duration of therapy varied among the participants. Of all the respondents, 228 (59.7%) 
had been on ART for the past three years (Table 4.2). About 152 (39.8%) had been on ART for 
less than three years while only 2 (0.5%) had recently commenced ART as at the time of the study 
(Figure 4.2). About 258 (81.6%) of the participants were open about their HIV status to those they 
are having sexual relationship and 58 (18.4%) were yet to do so.  Among those participants that 
were sexually active, about 241 (77.5%) were aware of the zero statuses of their sexual partner 
while 22.5% of them did not know the HIV zero status of their spouse/partner (Table 4.2). 
The majority of respondents 173 (45.3) were taking a TDF/3TC/EFV-containing regimen followed 
by an AZT/3TC/NVP combination 78 (20.4%), and AZT/3TC/EFV 58 (15.2%) while the 
























few were on second line regimen 28 (7.1%). The majority of the participants were reporting no 
side effects 283 (74.1%) (Table 4.2). 
Participants identified different barriers to adhering to ART. Three-quarters of them 285 (74.6%) 
said travel or migration was not a barrier to adhering to ART while only 97 (25.4%) indicated that 
frequent travelling or migration could be a barrier (Table 4.3). In the same vein, the majority of 
the participants did not regard any of the barriers to adherence asked in the questionnaire as 
constituting a hindrance to adhering to ART. Also, 340 (89.0%) of the participants had good 
perception of ART while only 42 (11%) of them had low perception of ART (Table 4.3). When 
looking at alcohol consumption, It was observed that over half of the participants 205 (53.7%) said 
that they did not consume alcohol while the remaining 177 (46.3%) said they consumed alcohol. 
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Table 4. 3 Barriers to adhering to ART among the study population 
 
4.4. FACTORS AFFECTING ADHERENCE TO ART 
4.4.1 Self-reported adherence to ART 
  A total of 382 participants responded to the question about adherence to ART. The number of 
participants who in the last four days had not missed any dosage days before the study was 354 
(92.7%) as a measure of self- report (Figure 4.3). This tool of measurement indicated that the 
proportion of those who adhere is lower in males (88.5%) than in females (95.1%). In this study, 
the percentage of those living in an urban area using this tool of measure is higher (94.9%) than 
those living in a rural area. Adherence to ART was also significantly greater in those with one 
form of education or another. This tool  indicated a higher percentage of adherence among those 




between adherence levels and the age of the participants (p<0.000). Adherence was 
proportionately higher in those that did not consume alcohol compared to those that consumed 
alcohol (95.1% and 89.8% respectively). The perception of the respondents about ART was found 
to be associated with ART adherence. Those with a positive perception about ART had a higher 
self- reported adherence (96.8%) compared to those with negative perception about ART (59.5%). 
The same goes for those that were open about their relationships and those whose partner confided 
in them (Table 4.4b).  
4.4.2 Appointment Renewal 
The majority of the participants honoured their appointment renewal to ART 331 (86.6%) (Figure 
4.3). There was no decrease in the proportion of people who honoured their appointment overtime 
as the duration of therapy increases as seen in Table 4.4b (86.8%). The percentage of participants 
who honoured their appointment renewal was higher among the participants with a high school 
education (91.3%) and in those who did not drink alcohol (92.7%; p<0.001). The proportion was 
also high among participants who had a positive view of ART (93.5%). Also, the HIV status 
disclosure and knowledge of HIV serostatus of the sexual partner were associated with 
appointment renewal to ART. The duration of treatment is not a barrier to adherence appointment 
renewal as shown in Table 4.4b. The therapeutic line was also significantly associated with 
appointment renewal to adherence as indicated in Table 4.4b (88.1%; p<0.001). 
4.4.3 Pills count Adherence 
 The pill count adherence measure of the participants stood at 83.2% (Figure 4.3). This showed 
that 318 of the participant have complied with 95% of their ART or more (Table 4.4a). This tool 
of measurement indicated that adherence increased significantly in the respondent’s place of 
residence. Participants living in urban areas were more likely to be adherent according to this tool 
of measurement (77.5%; p<0.005). This proportion of adherence was high among the participants 
with a high school education (86.5%). Also, the proportion of adherent participants that had a 
positive perception about ART was 305 (89.7%) (p<0.001). There was a statistically significant 
linear relationship between participants ART perception and pill count as a measure of adherence 
though the strength of the association was moderate. Pill count adherence was also associated with 




the HIV zero status of the sexual partner (p<0.001) had a positive relationship with the pill count 
measure of adherence (Table 4.4b). 
4.4.4 Global Adherence to ART 
Of the 382 participants who responded to questions about adherence, 325 (85.1%) were found to 
comply with global adherence to ART (Figure 4.3). The global adherence was calculated using the 
three tools of measurement for adherence, namely self-report adherence, pill count adherence and 
lastly the number of appointment honoured three months prior to the study (Figure 4.3). There was 
an association between the perception about ART and global adherence in the analysis (p<0.000). 
Also, there was an association between alcohol intake and adherence (p<0.000). The disclosure of 
the participants’ status (p<0.002) and status of the sexual partners’ knowledge (p<0.000) were also 
associated with global adherence. The global adherence was also statistically associated with the 
level of education (p<0.000), age (p<0.011) and marital status (p<0.028). Furthermore, statistical 
association was found between global adherence and place of residence (p<0.000), clinical WHO 
stage (p<0.000), the therapeutic line (p<0.000), side effects (p<0.000), duration of treatment 
(p<0.000), frequent travel or migration (p<0000), being too busy (p<0.000), and distance from the 
clinic (p<0.000) (Tables 4.4a – 4.4c).  
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4.5 CORRELATIONS ANALYSIS 
All the variables were tested for significant relationships using Pearson correlation analysis. This 
correlation analysis was run to assess the relationship between global adherence and the 
independent variables. There is a positive correlation between educational status and global 
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shown in Annexure H. Likewise, there is moderate positive correlation between global adherence 
to ART and ART perception as shown by 1 = 1.506, p<0.000, 1df in  Annexure H. Therefore this 
moderate positive relationships between educational levels, ART perception may be taken to 
influence adherence outcomes among the participants. Also, there was also a positive correlation 
between HIV status disclosures, Knowledge of HIV serostatus of sexual partner as shown in 
Annexure H. The interpretation of these findings is that there was a synergistic relationships among 
some of the independent variables and global adherence. Participants having a favourable 
perception of ART are likely to adhere to ART. 
4.6 REGRESSION ANALYSIS 
Multiple regression analysis has been widely used in statistics. They are important in studying and 
analysing the effects of various independent variables on the dependent variables.(59)     The 
relationships between the dependent variable which is adherence and the best linear combinations 
of the predictors is known as multiple correlation coefficients. In this study, multiple regression 
analyses were run for all the significant independent variables in the bivariate analysis to appreciate 
the adjusted effect to derive the adjusted odds ratio (aOR). The multiple regression was done to 
predict the independent variables that influence global adherence to ART among the participants. 
The multiple regression model statistically predicted educational status, knowledge of HIV status 
and ART perception as influencing adherence to ART. The p-value, adjusted odds ratio (aOR) and 
the confidence interval of the educational status and ART perception are found in the Annexure 
G. Thus, participants with a primary school education were likely to be about 12.6 times to be 
adherent to ART (p<0.018) whereas, participants with educational level equivalent to high school 
were likely to be 36 times adherent to ART (p<0.000). In contrast, participants with tertiary 
education were 88 times likely to be adherent to ART (p<0.000). Participants who have HIV status 
knowledge of their partner were 0.090 more times likely to be adherent to ART (p<0.020). Also, 
participants who had a positive view of ART  were 0.005 times more likely to comply with 
adherence to ART in contrast to those with poor perception (p<0.000).  
4.7 CONCLUSION 
The research results presented in this chapter reveal that the majority of the participants were 




area. Furthermore, the results showed that the majority of the participants have been living with 
HIV for more than three years, on clinical WHO stage one of the disease and the first line regimen. 
While the results of the study revealed a positive perception of ART among the participants, 
adherence measures from the individual and global tools was still sub-optimal. Several factors 
were found to be statistically significantly associated with adherence in the bivariate analysis. 
Among these factors are age, place of residence, therapeutic line, Clinical WHO stage, educational 
level, side effects, HIV status knowledge of the partner and HIV status disclosure of the 
participants. However, the multivariate analysis of these significant factors indicated that only 
three factors influenced adherence in this study. The next chapter discusses the results of the study 














CHAPTER 5: DISCUSSION, CONCLUSIONS AND RECOMMENDATIONS 
5.1 INTRODUCTION 
 While the previous chapter dealt with analysis and interpretation of the research findings, this 
chapter discusses the results of the investigation, its implications regarding adherence to ART and 
the research limitations. Furthermore, this chapter offers recommendations for improving 
adherence to ART. 
5.2  DEMOGRAPHIC CHARACTERISTICS OF THE PARTICIPANTS 
The majority of the participants were in their productive years with the age distribution ranging 
from 18 to above 45 years. Thus, it is in tandem with the pattern of age distribution released by 
the Lesotho demographic health survey which stated that the majority of the HIV infections 
occurred in the age groups 15-49 years.(70)  In this study, the majority of the participants were 
females (63.6%). This confirms the fact that women are disproportionately affected by the 
epidemic in Lesotho and Sub-Saharan Africa.(26, 70, 71) Some reasons have been attributed to this. 
Gender-based violence has been found to be one of the drivers of the outbreak.(71) The patriarchal 
nature of the society has entrenched gender inequality and continues to fuel gender-based violence. 
A study done in Lesotho concluded that 62.5% of men believed in resulting to violence if the 
spouses refused to have sexual intercourse with them while 37.1% of women believed this to be 
justified.(70) It is therefore not surprising that the majority of the participants are female and are on 
ART compared to their male counterparts. Earlier studies done corroborated this assertion.(72)  The 
number of participants on ART in this study above 45 years was 199 (52.1%) which may indicate 
some people on ART are living longer and enjoying the desired quality of life. 
The majority of the participants had primary school education 212 (55.5%) while a total of 156 
participants were married (40.8%) and 33.2% of the respondents were widowed. Most of the 
participants lived in urban areas 296 (77.5%) while 86 (22.5%) of the participants lived in the 
countryside. Access to health care has been described as one of the factors militating against 
delivery of health care services. It was established that access to health care services is influenced 
by gender, socio-economic status and geography with about 72% of women unable to access health 




hindering health care service provision.(70) Over half of the respondents on ART said they did not 
drink alcohol 205 (53.7%) while the remaining177 (46.3%) said they drink alcohol. 
5.3 ADHERENCE TO ART 
Three different tools of measure of adherence were used in this study to examine the global 
adherence of the participants. Pill count adherence was the first method used in calculating the 
global adherence to ART, and 83.2% of the participants were found to be adherent. It has been 
demonstrated that adherence to medication is secondary to CD4 count in determining the 
progression to AIDS and eventual death(35).  Studies have shown that adherence of over 90% 
significantly reduces the progression of HIV to AIDS using this method of adherence compared 
to adherence of 51-90% that recorded 8% mortality.(35, 73)  However, the barrier to adherence does 
not in any way influence the pill count as a measure of adherence. The participants all have a 
positive outlook towards their therapy. This may be connected to the availability of medication 
and free treatments being offered by the Lesotho Ministry of Health.  The other tool of measuring 
was appointment adherence to ART which indicated that 86.6% of PLWHA were able to honour 
their appointment, three months before the study.  
The third method of choice in measuring the global adherence in this study was the self-report. 
The self-reporting tool indicated that 92.7% of the participants had good adherence. Similar studies 
conducted in Nigeria reported a lower rate (62.8%).(11)  In the same vein, a study carried out in 
California recorded 95-99% adherence using self-report as a measuring tool.(74) The self-reporting 
method of measurement, without doubt, is subjective, but it was applied in this study to eliminate 
recall bias and is a commonly used method in measuring adherence to ART among PLWHA.(30, 
37, 39, 75)   Aside from the fact that these methods are not financially demanding,  they are easy to 
implement, and the combination of one or two of them yield a more reliable result.(76) 
The global adherence of the participants in this study was 85.1% as calculated from the self-report 
adherence, pill count and appointment adherence methods which was sub-optimal because it was 
less than 95% though it was higher than those reported by Mills et al.(27) at 55% and less than that 
reported in the study conducted by Nachega(77) which recorded 95% adherence among participants. 
It is widely acknowledged that there is a correlation between adherence and clinical outcomes. In 




PLWHA to prevent virologic failure occasioned by the development of drug-resistant virus.(39, 78)  
The global adherence rate in this study was less than 95% despite the fact that for maximum viral 
suppression to be achieved, near perfect adherence is needed.(35)  In this study, 14.9% of the 
participants were found to be non-adherent. The implication of this is that the eventual virological 
failure impacts the possibility of clinical success in the long-term. The attendant development of 
drug-resistant strains of HIV in the face of ART poses a danger to the uninfected people as these 
strains can be transmitted leaving them with very narrow treatment options.(79) 
The ART adherence reported in this study was comparable to the studies carried out in Kenya 
which reported adherence rate of (82%).(80) It was also comparable to the ones done in Nepal 
(85.5%)  and West Africa (91.8%) by Wasti et al.(81) and Jaquet et al.(82) respectively. The result 
of this study was higher than the meta-analysis study which found out that 77% of patients were 
adherent in Africa(27) and to the one conducted in the Southern part of Ethiopia.(83)  The finding 
was also higher than the study carried out by Achappa(37) that reported an adherence rate in India 
to be 74%. It should be noted that the difference in the adherence rates across different studies may 
be influenced by the context and the various methods of adherence measurement used by other 
studies. 
5.4 FACTORS ASSOCIATED WITH ADHERENCE 
It is essential that highest level of adherence must be obtained to achieve the best possible 
outcomes in the management of PLWHA (over 95% adherence). Various factors have been 
implicated having influence adherence in ART patients. These factors varies from region to region. 
In this study, the global adherence of the participants was recorded to be 85.1% indicating that 
adherence was suboptimal (<95%). It is imperative to state that three factors were found to 
influence global adherence to ART among the participants. These are the educational status of the 
participants, HIV status knowledge and ART perception.  
This study demonstrated that participants with good ART perception are most likely to follow their 
drug regimen. It has been shown that self-efficacy in the effectiveness and belief is a predictor of 
adherence to medication as demonstrated by various studies.(20, 84, 85) Self-efficacy has been shown 
to influence adherence to chronic medication widely, and it has been implicated in the adherence 




able to incorporate health-promoting behaviour such as self-beliefs were able to control their 
thoughts processes and have favourable perception of ART.(81, 86) This is primarily because their 
health conditions have improved and are healthy.(86)  A mixed method study conducted in Nepal 
found out that poor adherence was associated with negative perception.(81)  
In the same vein, patients’ use of medication is influenced by the perception they have towards the 
drugs.(9)  The perception to ART will be affected by the positive or negative attitude towards the 
medication. In this study, the majority of the participants had favourable perception towards ART. 
The study underscores the cost-benefit analysis that the participants must have done to have a good 
perception and the importance of promoting health education both in the ART clinic and the 
communities so as to overcome the barriers such as side effects of the ARVs militating against 
adherence. 
Secondly, educational level was found in the study as one of the predictor of adherence to 
medication. Education has been shown to play a meaningful role between ART patients and 
adherence to medication.(87) In this study, educated participants are likely to adhere to treatments 
compared to their counterparts who are uneducated. Education serves as a medium through which 
information is disseminated to the clients. People with a higher education may exhibit better 
adherence to ART because of their ability to comprehend instructions given by their service 
providers.  
Various studies have been done to buttress the importance of education in adherence.  Studies 
conducted in Keffi, Nigeria by Pennap(11) highlighted the importance of formal education in 
adherence. The study found out that the adherence rate was higher among clients with formal 
education. Likewise, a study conducted in Nepal by Wasti(81) supported the fact that the adherence 
rate was higher among patients’ who are educated whereas Kalichman et al.(88) in a study 
conducted in the United States of America found out association between low educational status 
and non-adherence. It was reported that an inability to assess HIV-related care and adherence was 
due to lack of education among those patients. 
However, the above report is at variance with some studies conducted in the developing countries. 
Non-adherence was found among the educated groups in a study undertaken in Ilorin, Nigeria by 




group of participants. This group of people attributed their non-adherence to their busy schedule.(89, 
90)   Another study conducted by Okoronkwo et al.(91) at the retroviral clinic of the Nnamdi Azikwe 
University Teaching Hospital, South East, Nigeria did not find any association between education 
and adherence. 
Similarly, participants status knowledge played a role in adherence. The findings of this study 
demonstrated that the majority of the participants were aware of their HIV status and were 
knowledgeable enough about ART. Documented evidence suggests that with appropriate 
treatment and continued adherence to medication; HIV can be turned into a chronic disease.(9) 
Knowledge of HIV zero status could create a two-fold nature of social support systems. It could 
lead to a lack of support and on the other hand it could serve to enhance adherence.(92)  The issue 
of stigma is still prevalent in Lesotho. While some people remain accepting and supportive, others 
might not. HIV status knowledge will create an avenue for family members to remind participants 
of the need to take their medication and offers support while creating a channel for constant 
communication and knowledge.(27, 81)  A study conducted by Remien(84) elucidated that the social 
support  played a positive role thus the family serves as fulcrum in promoting adherence. In a 
meta-analysis study done, patients with cohesive families were found to be 1.74 times more 
adherent.(93)  On the other hand, its absence had been implicated in non-adherence.(94) It is 
imperative that health care providers continue to engage and encourage PLWHA to foster support 
and facilitate adherence. 
An analysis of other factors found no association between these factors and adherence to ART. 
This is in contrast to evidence from elsewhere. For example Glass et al(95) indicated that substance 
abuse and alcohol are linked to poor adherence to medication which most often than not lead to 
poor outcomes in the treatment of HIV.(95) The use of recreational drugs and alcohol have been 
associated with non-adherence. The substances have been implicated in preventing adherence in 
HIV-infected individuals on lifelong medication.(95)  Excessive alcohol intake is associated with 
men living with HIV as they are constantly reminded through daily dose of ARVs.(96)  
Furthermore, several studies done in Sub-Saharan Africa have implicated socio-economic factors 
in hindering adherence to ART. These studies were carried out in multiple setting in the sub-




some indirect costs linked to adherence to ART. Some of these are; the time taken from work, the 
number of days spent in the hospitals and general inability to provide for the family as a result of 
the debilitating effect of HIV.(97) 
Though the present study assessed the relationship between adherence to ART and the duration of 
being on ART therapy and the type of ART regimen, these two factors were also not associated 
with adherence to ART. The majority of the participants 228 (59.7%) have been on ART therapy 
for more than three years which was an indication that they have been living with HIV and AIDS 
disease for more than three years. Of those who were sexually active, the majority of them had 
disclosed their HIV status to their sexual partner 258 (81.7%). Disclosure of their HIV status by 
sexually active participants is an indication of acceptability of their condition which is critical in 
adherence to ART. Various studies corroborated the view that people living with HIV and AIDS 
who disclosed their status, having been engaged in care will most likely adhere to treatment. (95, 98)  
According to Nachega(77), it is essential that social support and disclosure be inherent issues to be 
considered when assessing clients for adherence. One of the biggest challenges facing PLWHA is 
stigma and discrimination.(99)  In Lesotho, stigma and discrimination remains a major issue in 
preventing people accessing treatment and support services. These range from verbal to physical 
abuse as well as exclusion from social gatherings. According to Lenepwha (100)  as high as 41.1% 
of the people interviewed had the experience of people gossiping about their status while 26.8% 
reported verbal abuse. It is therefore not surprising  that some ART clients prefer taking their 
medication in secret, thus compromising their adherence.(97) Also, the length of ART  therapy and 
duration of been diagnosed with HIV is pivotal in influencing adherence to ART.(103)   This in 
contrast to a cohort study done which implicated the duration of the disease. The longer the time 
of living with the disease, the less one is likely to adhere to treatment. (95) 
Adherence to ART has been linked to healthy and positive clinical outcomes, thus stopping the 
virus from being replicated, improving the response of the immune system and lowering the viral 
load.(101)   Research has shown that good adherence levels have been linked to good clinical 
outcomes. Thus, patients suffering from opportunistic infection before ART initiation will be 




Research conducted on ART among people living with HIV showed an association between 
adverse drug reaction and adherence. Untoward side effects of the ARVs have been linked with 
poor adherence.(98, 104)  However, the majority of the participants in this study indicated no adverse 
reaction to their medication as a barrier to adherence 283 (74.1%). This may have influenced the 
high level of adherence reported (85.1%) in the study. It is possible because of the limited resources 
in this area and to prevent the attendant comorbidity and opportunistic infections; PLWHA are 
more than willing to accept the side effects of these medications. Also, research carried out in 
Botswana found no association between adherence to ART and the adverse effects of ART.(105) 
The increasing HIV morbidity and mortality have been associated with poor adherence due to the 
significant side effects of the ART therapy by various studies conducted. (95, 102)  As a result, it has 
been advised that the health care providers should consider individual patient's circumstances 
before engagement, linkage to care and ART initiation.(106)  The advent of single dosage regimen 
have significantly reduced pill burden and promoted simplified antiretroviral therapy regimen, 
which in the long run promoted adherence to ART.(102, 106, 107)    
5.5 SUMMARY OF FINDINGS  
The study was designed to provide a better understanding, determine the level of adherence to 
ART and to document those factors associated with antiretroviral therapy adherence in Quthing 
District, Lesotho, and the information obtained can be used to proffer recommendations to enhance 
adherence to ART. This section summarises the research findings and conclusion. This section 
looks at the extent to which the objectives of the study have been met. 
5.5.1 Objective 1: To establish the proportions of patients that adhere to antiretroviral 
therapy received from   Quthing District Hospital and Villa Maria Health Centre in Lesotho. 
The objective was achieved through conducting a research using bivariate analysis. Data were 
collected from the participants living with HIV and on ART. Descriptive data was analysed using 
quantitative instruments. The research findings indicated that the proportions of the participants 
who are adherent to ART are more than 80% in each of the three methods used to measure 
adherence with an overall adherence of more than 85%. These findings revealed that the adherence 




5.5.2 Objective 2: To determine factors influencing adherence to antiretroviral therapy 
received from Quthing District Hospital and Villa Maria Health Centre in Lesotho 
The second objective was met through the use of correlation and regression analysis of the 
descriptive data. The predictors of adherence to ART were demonstrated by analysing the 
relationships between the independent variables and dependent variable. The statistically 
significant variables were further subjected to multivariate regression analysis to determine the 
factors influencing global adherence in the study. Three factors were found to be predictors of 
adherence to ART, that is, educational level, knowledge of HIV and ART perception. 
 
5.5.3 Objective 3: To determine the knowledge of HIV and practice of ARVs among 
PLWHA in Quthing District Hospital and Villa Maria Health Centre in Lesotho. 
Referencing this section to the HBM, the descriptive data of the participants demonstrated that the 
majority of them had a favourable perception towards ART. Their knowledge of HIV and practice 
of ARVs was demonstrated in them having been able to determine the stage in which they are, the 
duration of their treatment and the different type of ART.  It was also recognisable in the fact that 
the majority of the participants recognised the importance of adherence to ART as this will increase 
their life expectancy once they are placed on it. 
5.6 LIMITATIONS OF THE STUDY 
The result of this study are not without limitations.  Firstly, the study made use of a cross-sectional 
design which tends to measure adherence at a single point in time, thus limiting the causal 
inference. It does not provide for the variation of adherence of the participants that may occur over 
time. Therefore, it is important that measures such as longitudinal studies should be employed in 
these settings. Longitudinal studies are capable of reaching wider participants and make use of 
different assessment tools which are essential in understanding adherence over time. Factors that 
influence adherence to ART can be investigated in the long term thus precluding over-estimation. 
 
Secondly, the fact that the study was conducted in a public health facility that offers free ART 
services may have led to over-estimation of adherence. Socio-economic barriers to adherence that 




This may have played a role in the responses of the respondents to the questions on barriers to 
adherence. 
 
Thirdly, other possible predictors of adherence to ART were not explored and investigated. Such 
predictors as transportation cost, roles of service providers and social support. Fourthly, Self-report 
questionnaire could have been affected by recall bias, the desirability in responding positively and 
patient’s motivation. This could lead to over-estimation of adherence by the participants while the 
actual picture of non-adherence is not reported. It is possible that other measures of adherence such 
as laboratory blood monitoring, medication events monitoring systems (MEMS) may have given 
different results. 
 
Finally, the study was conducted in Quthing District only, and therefore may not be 
representative of adherence to ART of PLWHA in Lesotho. 
5.7 RECOMMENDATIONS 
The researcher is of the view that the following recommendation should be followed to enhance 
adherence to ART among PLWHA. 
 
a) It is imperative that baseline screening should be obtained on all patients being initiated on 
ART to obtain baseline data on adherence. This may help the service providers to recognise 
clients that will need further intervention before ART initiation. 
 
b) Health education campaigns still need to be intensified to address stigma and 
discrimination of PLWHA. 
 
c) High level of adherence may not be a guaranteed adherence for a long time. It is, therefore, 






d) The study has shown that more females are affected than males which reflected the number 
of participants attending clinic. Efforts should be geared towards developing programmes 
that specifically target men. These programmes should be implemented with a view of 
diagnosing, linking them to care, initiation and retaining them in care. The programmes 
should also assist in educating them on gender issues relating to HIV and AIDS. 
 
e) It is important that future studies utilise multiple measurements of adherence to validate 
the accuracy of other measures such as self-report. 
 
f) Different health care providers such as faith-based organisations may be incorporated into 
the future research. This will encourage sharing of ideas in the strategies used to initiate 
and sustain adherence among their ART clients. This collaboration may help gain a better 
understanding of potential obstacles to adherence among clients not yet initiated. 
 
g) The present study did not deal with patient-provider relationship regarding the influence 
the provider exert on the patients that will affect their adherence to ART. In future, a further 
study may be carried out to explore this relationship and how it influences adherence. 
 
h) It is essential that the service provider should regularly be empowered as the knowledge 
gained will be used to disseminate information that is not only appropriate but improve the 
patients’ understanding of adherence, what is expected of them and what should be done. 
Communication channels should be kept wide open at all times between the service 
providers and the patients as self-efficacy develops over time. Therefore, positive 
reinforcement is necessary to promote adherence to ART among PLWHA.  
 
i) Different approaches to enhance adherence should be employed. Approach such as 
modelling behaviour can be utilised. HIV positive patients who are adherent can be used 
to reinforce self-care behaviours. This can be utilised by the health care providers in 







It is important to note that HIV is a chronic disease that can be managed with medications to ensure  
successful clinical outcome. The successful clinical outcomes rest on appropriate clinical 
management as well as the patient’s positive belief reinforced by self-efficacy in ensuring 
adherence to ART. In this study, the adherence level in the Quthing District Hospital and Villa 
Maria Health Centre was Sub-optimal. Educational attainment, Knowledge of HIV status and the 
perception to ART were the main predictors of adherence to ART.  It is, therefore, important that 
relevant policy makers, non - governmental organisations and service providers prioritise 
interventions aimed at promoting regular follow-up, updating and constant education of PLWHA 
on adherence, risk of non-adherence and issues relating to HIV and AIDS. 
Also, an attempt should be made to provide enabling environment to the health care service 
providers that is supportive of PLWHA so that people living with HIV could have the structural 
and emotional support for partners to both be open about their individual zero-status. As 
knowledge regarding health and individual beliefs is not enough to achieve behaviour change 
modifications, efforts should be geared towards understanding other behavioural modification and 
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ANNEXURE C:  CONSENT FORM ENGLISH 
INFORMED CONSENT FORM 
Greetings, 
My name is Oluwasola Afolabi Abiodun, and I am a master’s student at the University of 
KwaZulu-Natal (UKZN), Howard College Campus. I am conducting a research study on better 
understanding of the level of adherence and factors associated with it. This research process forms 
part of my Master’s thesis entitled: 
“Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS 
at the Quthing District Hospital and Villa Maria Health Centre, Lesotho”. 
The study aimed to understand better and explain why people living with HIV adhere or do not 
adhere to their medication. The result might help to inform future interventions in the district. 
Please be advised that you may choose not to participate in this research study, and should you 
wish to withdraw at a later stage, you have the full right to do so, and your actions will not 
disadvantage you in anyway. You are invited to participate in the research by answering a few 
questions that I will ask you. If you volunteer to participate in this study, we would ask you to 
respond to a questionnaire with 20 questions. 
 The study asks about adherence to antiretroviral therapy that may be unpleasant to recall. These 
questions could stir up feelings that may cause some discomfort. Additional risks associated with 
your participation in this study are: having confidential information collected, being asked personal 
questions, and being inconvenienced by the time spent in the interview (a total of about thirty 
minutes to one hour). In the event that any participant experiences discomfort, the researcher will 
stop the questions and allow for such information to be omitted. Depending on the circumstances, 
the researcher will avail the participants opportunity to speak to a counsellor if they so wish. The 
following registered counsellors will be on hand to offer counselling and psychosocial support. 
Mary Matobo mary_matobo@yahoo.com +26658032671 




There is no material or financial benefits attached to participating in this research study, and your 
participation is entirely voluntary. The information obtained from you will be treated in a 
confidential manner, and will be safely stored at the University of KwaZulu-Natal. Your input will 
add significant value to the research project and increase knowledge in the area of adherence to 
antiretroviral therapy. 
Should you need further clarity or have any questions regarding this research study, please contact 
me or my research supervisor. 
Researcher:                                                                         Research Supervisor 
O. A. ABIODUN                                                                Prof Joyce Tsoka-Gwegweni 
Tel +26657515171                                                             Tel +27312604386 
Email: drabiodun@yahoo.com                                           tsokagwegweni@ukzn.ac.za 
Your participation is much appreciated, thank you. 
 
DECLARATION 
I……………………………………………………….. hereby declare that I am fully aware of the 
contents of this Informed Consent Form and the nature of this research project. I fully agree to 
participate in this research project as a volunteer, and, therefore, I have the right to refuse to answer 
any questions. 
I also have the right to withdraw from this research study at any point, should I wish to do so, and 
my actions will not disadvantage me in any way. I will not receive any payment for participating 
in the research. 
 






ANNEXURE D: CONSENT FORM SESOTHO 
LITLATSETSO 
Tlatsetso ea 1: Foromo ea tumello 
FOROMO EA TUMELLO 
Ea Nkang Karolo 
Lebitso laka ke Oluwasola Afolabi Abiodun ‘me ke moithuti oa lengolo la Masters Sekolong se 
Seholo sa Kwa-Zulu Natal (UKZN) Howard College. Ke etsa boithuto holim’a kutloisiso e ntle 
mabapi le bokhomareli ba se itseng hammoho le tsohle tse amanang le taba ena. Boithuto bona ke 
karolo ea sengoloa sa ka sa lengolo lena la Masters seo sehlooho sa teng e leng: 
“Predictors of adherence to antiretroviral therapy among people living with HIV and AIDS 
at the Quthing District Hospital and Villa Maria Health Centre, Lesotho”. 
(Matšoao a tšepahallo ea litlhare ho batho ba phelang le HIV le AIDS Sepetleleng sa Quthing le 
Setsing sa Bophela sa Villa Maria, Lesotho).  
Sepheeo sa boithuto bona ke ho utloisisa hantle le ho hlalosa hore na ke hobaneng batho ba phelang 
le kokoana-hloko ea HIV le AIDS ba phehella kapa hona ho se phehelle ho sebelisa litlhare tsa 
bona. Sephetho se ka thusa ho etsa khoeletso ea lithuso tsa ka moso seterekeng. Hlokomela hore 
u ka khetha ho se nke karolo boithutong bona ‘me ha u ka lakatsa ho ikhula hamorao, u na le tokelo 
eohle ea ho etsa joalo, ‘me seo u se etsang ha se na ho sebetsa khahlanong le uena ka tsela efe kapa 
efe. U kopuoa ho nka karolo puisanong e tataisoang ke lipotso. 
Boithuto bona bo botsa ka ho phehella ho sebelisa lithlare tsa kokoana hloko ea HIV le AIDS tseo 
ho ka etsahalang hore ebe ha ho monate ho li hopola. Lipotso li ka tlisa mepolo eo u ka utloang e 
u beha tlasa moea oa khatello. Tse ling tsa ntho tse ka u behang tlokotsing mabapi le boithuto bona 
ke : ho batloa litaba tse amanang le lekunutu la hao u  le mokuli, le ho botsoa lipotso tse batlang 
litaba tsa bokulo ba hao, le ho nka nako tetelele o botsoa lipotso(nako e ka bang metsosto e 
mashome a mararo ho isa ho hora). Ha u utloa eka moithuti u tla u hata litorong u lumelletsoe ho 




lumelletsoe ho bua le mohlabolli haeba ba ikutloa joalo. Bahlabolli ba teng semmuso ba latelang 
ba tla ba teng ho fana ka thuso: 
Mary Matobo mary_matobo@yahoo.com +26658032671 
Mejoane Mohapi mejoanefm@gmail.com +26658107877 
 
Ha ho litsiane tsa mofuta ofe kapa ofe tse tsamaeang le ho nka karolo ha hau boithutong bona, ka 
hona ho nka karolo ha hau empa e le boithapo feela. Litaba tse tla fumanoa ho tsoa puisanong eo 
li tla sebelisoa e le lekunutu ‘me li tla bolokoa Sekolong se Seholo sa Kwa-Zulu Natal. Ke leboha 
ho nka karolo ha hau boithutong bona ‘me tlatsetso ea hau e bohlokoa haholo boithutong bona. 
Haeba u ka hloka tlhalosetso e fetang mona kapa oa ba le lipotso mabapi le boithuto bona, bua le 
‘na kapa mosupisi oa ka. 
 
 
Moithuti:      Mosupisi: 
O. A. ABIODUN     Prof. Joyce Tsoka-Gwegweni 
Mohala: 266 57515171    Mohala: +27312604386 
Email: drabiodun@yahoo.com    tsokagwegweni@ukzn.ac.za  













‘Na………………………………………………………….. ke itlama mona hore ke utloisisa 
tsohle tse ka hare ho foromo ena hammoho le boleng ba boithuto bona. Ke lumela ka ho tiea ho 
nka karolo boithutong bona ke le moithaopi ‘me kena le tokelo ea ho hana ho araba potso ea mofuta 
ofe kapa ofe. 
Ke boetse ke na le tokelo ea ho ikhula boithutong bona nako eohle e-bang nka lakatsa ho etsa joalo 
‘me sohle seo ke tla se etsa ha se na ho sebetsa khahlanong le ‘na ka tsela efe kapa efe. Ha ho 
litsiane tsa mofuta ofe kapa ofe tse tsamaeang le ho nka karolo boithutong bona. 
 
















ANNEXURE E: RESEARCH INSTRUMENT, ENGLISH 
QUESTIONAIRE ON PREDICTORS OF ADHERENCE TO 
ART       
             
 
      
           
             
1. Sex      
 n 
(%)       
Male              
Female              
             
Age             
Less than 25             
25-35 years             
35-45 years             
More than 45             
             
3. Marital status            
Single              
Widower              
Divorced              
Married              
             
4. Educational level            
Non Schooled             
Primary School             
High School             
Tertiary Level             
             
5.Religion            
Christian              
Islam              
None or Traditional             




6.Place of residence            
Urban              
Rural              
             
7. Alcohol consumption           
Yes              
No              
             
8.Clinical WHO stage           
Stage I              
Stage II              
Stage III and IV             
             
9. Duration of ART therapy           
Less than one year             
1 to 3 years             
More than 3 years             
             
10. CD4`s count( Last check-up)          
CD4<350              
CD4>350              
             
11. Therapeutics` line           
1st Line              
2nd Line              
3rd line              
             
12. Type of ART prescribed           
TDF/3TC/NVP             
TDF/3TC/LPV/r or ATV/r            
AZT/3TC/LPV/r or ATV/r            
ABC/3TC/NVP             
ABC/3TC/EFV              
AZT/3TC/EFV             
ABC/3TC/LPV/r             
AZT/3TC/NVP             




             
13. Reported side effects           
No              
Yes              
             
14.ART perception by patient           
Low              
Good              
             
15. HIV-Status disclosure to sexual partner         
No              
Yes              
             
16.Knowledge of the HIV zero-status of the sexual partner        
No               
Yes              
             
17. Self-reported 4 - day recall dose adherence to ART        
No              
Yes              
             
18. Appointment`s adherence to ART          
No              
Yes              
             
19. Pills count`s adherence to ART          
No              
Yes              
             
20. Barriers to treatment            
20.1 Duration of treatment too long          
No              
Yes              
             
20.2 Side effects with ARV medication?          
No              
Yes              




20.3 Frequent travel or migration?          
No              
Yes              
             
20.4 Is hunger a barrier to treatment          
No               
Yes              
             
20.5 Overall economic situation a barrier          
No              
Yes              
             
20.6 Too busy            
No              
Yes              
             
20.7 Distance from clinic           
No              
Yes              
             
21 Global adherence to ART           
No              
Yes              











ANNEXURE F: RESEARH INSTRUMENT, SESOTHO 
QUESTIONNAIRE            
LIPALO-PALO TSE HLALOSANG BATHO BA PHELANG LE KOKOANA-HLOKO EA 
HIV     
 
LE AIDS BA TLASA TS`EBELSO EA LITHLARE SEPETLELENG SA MMUSO QUTHING     
Boleng ba bakuli            
             
1. botona kap bots`ehali    
 n 
(%)       
Botona              
Bots`ehali              
             
2. Lilemo             
Tse ka tlase ho 25             
Lilemong tse 25-35             
lilemong tse 35-45             
ka holimo ho 45             
             
3. Boemo ba lenyalo            
Ka thoko ho lenyalo             
Ea lahlahetsoeng ke molekane ka lefu( mohlolohali/Mohlolo)         
Thlalo              
Ka hare ho lenyalo             
             
4. Boemo ba thuto            
ea sa kenang sekolo             
Sekolo sa mathomo             
Sekolo se phahameng             
Setsi sa thuto e holimo             
             
5.Tumelo             
Mo-kriste              
Mo-moslam             
Molumeli oa setso             
             
 




6.Sebaka sa bolulo 
Toropong              
Mahaeng              
             
7. Ts`ebeliso ea tai            
Che              
E              
             
8.Mokhahlelo            
Mokhahlelo I             
Mokhahlelo II             
Mokhahlelo III             
             
9. Nako ea ts`ebeliso ea lithlare           
Ka tlase ho selemo             
Selemo ho is a tse tharo            
Ho feta lilemo tse tharo             
             
10. Palo tsa CD4 ( Tlhatlhobo ea ho qetela)          
ka tlase ho 350             
ka holimo ho 
350              
             
11. Mola oa therapeutics           
Mola oa pele             
Molaoa bobeli             
mola oa boraro             
             
12. Mofuta oa litlhare tse khothalelitsoeng          
TDF/3TC/NVP             
TDF/3TC/LPV/r or ATV/r            
AZT/3TC/LPV/r or ATV/r            
ABC/3TC/NVP             
ABC/3TC/EFV              
AZT/3TC/EFV             
ABC/3TC/LPV/r             




TDF/3TC/EFV             
             
13. Litlamorao tse tlalehiloeng           
Che              
E              
             
14. Tsela eo mokuli a amohelang lithlare ka eona         
E tlase              
E nepahetse             
             
15. Na molekane o tsebisitsoe ka boemo ba HIV?         
Che              
E              
             
16. Tsebo ea hore molekane ha a na HIV?          
Che              
E              
             
17. Ts`epahallo ea litlhare ea motho ka bo eena         
Che              
E              
             
18. Ts`epahallo ea lithlare ho latea letsatsi le beiloeng ho ea setsing sa bophelo      
Che              
E              
             
19.Ts`epahallo ea litlhare ho latela palo ea lipilisi         
Che               
E              
             
20. Lintho tse thibelang ts`epahallo           
20.1 Nako ea kalofo e telele haholo?          
Che              
E              
             
20.2 Litlamorao tsa litlhare           
Che              




             
 
20.3 Ho nka maeto hangata kapa ho tsoa le ho kena ka hara naha        
Che              
E              
             
20.4 Tlala ke thibelo ho kalafo           
Che              
E              
             
20.5 Maemo a akaretsang a morou ke thibelo         
Che              
E              
             
20.6 U phathahane haholo           
Che              
E              
             
20.7 Nako ea ho ea setsing sa kokelo          
Che              
E              
             
             
21. Ts`epahallo e akeretsang ho ART          
Che              
E              
             
             
             









ANNEXURE G: Predictor  of adherence of PLWHA to ART at QUTHING in LESOTHO 
  
B S.E. Wald df Sig. Exp(B) 
95,0% C.I.for 
EXP(B) 
  Lower Upper 
Step 1a GENDER(1) -.413 .637 .421 1 .517 .662 .190 2.306 
AGE   1.897 3 .594    
AGE(1) 2.730 2.354 1.345 1 .246 15.332 .152 1.545E3 
AGE(69) .922 1.080 .729 1 .393 2.514 .303 20.861 
AGE(3) -.342 .781 .192 1 .661 .710 .154 3.284 
MARITAL_STATUS   3.524 3 .318    
MARITAL_STATUS(1) .559 1.311 .182 1 .670 1.748 .134 22.856 
MARITAL_STATUS(69) .078 .776 .010 1 .920 1.081 .236 4.949 
MARITAL_STATUS(3) 3.038 1.630 3.472 1 .062 20.855 .854 509.090 
EDUCATIONAL_STATUS   18.773 3 .000    
EDUCATIONAL_STATUS(1) 2.532 1.072 5.575 1 .018 12.575 1.537 102.856 
EDUCATIONAL_STATUS(69) 3.582 .906 15.643 1 .000 35.948 6.092 212.127 
EDUCATIONAL_STATUS(3) 
4.476 1.269 12.434 1 .000 87.920 7.303 1.058E3 
RESIDENCE(1) 1.251 .882 2.010 1 .156 3.494 .620 19.701 
ALCOHOL_CONSUMPTION(1) .181 .601 .090 1 .764 1.198 .369 3.892 
CLINICAL_WHO_STAGE   5.141 2 .076    
CLINICAL_WHO_STAGE(1) -16.850 1.826E4 .000 1 .999 .000 .000 . 
CLINICAL_WHO_STAGE(69) -19.824 1.826E4 .000 1 .999 .000 .000 . 
THERAPEUTICS   .691 2 .708    
THERAPEUTICS(1) -16.519 4.019E4 .000 1 1.000 .000 .000 . 
THERAPEUTICS(69) -17.691 4.019E4 .000 1 1.000 .000 .000 . 
SIDE_EFFECTS(1) -1.217 1.093 1.240 1 .265 .296 .035 2.522 
HIV_STATUS_KNOWLEDGE(1) -2.408 1.034 5.423 1 .020 .090 .012 .683 
HIV_STATUS_DISCLOSURE(1) .463 1.067 .188 1 .664 1.588 .196 12.846 
ART_PERCEPTION(1) -5.397 1.318 16.758 1 .000 .005 .000 .060 
BARRIERS_TO_TREATMENT_2(1) -.573 1.104 .270 1 .604 .564 .065 4.904 
BARRIERS_TO_TREATMENT_1(1) 1.085 .807 1.808 1 .179 2.961 .608 14.409 
BARRIERS_TO_TREATMENT_3(1) 1.055 .912 1.340 1 .247 2.872 .481 17.148 
BARRIERS_TO_TREATMENT_6(1) -.124 .875 .020 1 .887 .883 .159 4.913 




Constant 33.932 4.415E4 .000 1 .999 5.454E14   
   


















GENDER(1) .517 .662 .190 2.306 
AGE .594    
AGE(1) .246 15.332 .152 1.545E3 
AGE(69) .393 2.514 .303 20.861 
AGE(3) .661 .710 .154 3.284 
MARITAL_STATUS .318    
MARITAL_STATUS(1) .670 1.748 .134 22.856 
MARITAL_STATUS(69) .920 1.081 .236 4.949 
MARITAL_STATUS(3) .062 20.855 .854 509.090 
EDUCATIONAL_STATUS .000    
EDUCATIONAL_STATUS(1) .018 12.575 1.537 102.856 
EDUCATIONAL_STATUS(69) .000 35.948 6.092 212.127 
EDUCATIONAL_STATUS(3) .000 87.920 7.303 1.058E3 
RESIDENCE(1) .156 3.494 .620 19.701 
ALCOHOL_CONSUMPTION(1) .764 1.198 .369 3.892 
CLINICAL_WHO_STAGE .076    
CLINICAL_WHO_STAGE(1) .999 .000 .000 . 
CLINICAL_WHO_STAGE(69) .999 .000 .000 . 
THERAPEUTICS .708    
THERAPEUTICS(1) 1.000 .000 .000 . 
THERAPEUTICS(69) 1.000 .000 .000 . 
SIDE_EFFECTS(1) .265 .296 .035 2.522 
HIV_STATUS_KNOWLEDGE(1) .020 .090 .012 .683 
HIV_STATUS_DISCLOSURE(1) .664 1.588 .196 12.846 
ART_PERCEPTION(1) .000 .005 .000 .060 
BARRIERS_TO_TREATMENT_2(1) .604 .564 .065 4.904 
BARRIERS_TO_TREATMENT_1(1) .179 2.961 .608 14.409 
BARRIERS_TO_TREATMENT_3(1) .247 2.872 .481 17.148 
BARRIERS_TO_TREATMENT_6(1) .887 .883 .159 4.913 
BARRIERS_TO_TREATMENT_7(1) .256 .326 .047 2.255 
     





ANNEXURE H. Correlation Matrix 
Global adherence to ART * HIV status disclosure to sexual partner 
 
Crosstab 
   
HIV status disclosure to sexual partner 
Total 
   
no yes 
Global adherence to ART no Count 13 22 35 
% within HIV status disclosure 
to sexual partner 
22.4% 8.5% 11.1% 
yes Count 45 236 281 
% within HIV status disclosure 
to sexual partner 
77.6% 91.5% 88.9% 
Total Count 58 258 316 
% within HIV status disclosure 
to sexual partner 















Pearson Chi-Square 9.272a 1 .002 
  
Continuity Correctionb 7.915 1 .005 
  
Likelihood Ratio 7.884 1 .005 
  
Fisher's Exact Test    .005 .004 
Linear-by-Linear Association 9.242 1 .002 
  
N of Valid Casesb 316 
    
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 6,42. 












Global adherence to ART * Knowledge of the HIV zero-
status of the sexual partner 
 
Crosstab 
   Knowledge of the HIV zero-status of 
the sexual partner 
Total 
   
no yes 
Global adherence to ART no Count 16 19 35 
% within Knowledge of the HIV 
zero-status of the sexual partner 
22.5% 7.8% 11.1% 
yes Count 55 226 281 
% within Knowledge of the HIV 
zero-status of the sexual partner 
77.5% 92.2% 88.9% 
Total Count 71 245 316 
% within Knowledge of the HIV 
zero-status of the sexual partner 



















Pearson Chi-Square 12.209a 1 .000 
  
Continuity Correctionb 10.755 1 .001 
  
Likelihood Ratio 10.582 1 .001 
  
Fisher's Exact Test    .001 .001 
Linear-by-Linear Association 12.171 1 .000 
  
N of Valid Casesb 316 
    
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 7,86. 
b. Computed only for a 2x2 table     




Value df Asymp. Sig. (2-sided) 
Pearson Chi-Square 18.074a 3 .000 
Likelihood Ratio 14.747 3 .002 
Linear-by-Linear Association 7.451 1 .006 

















Pearson Chi-Square 1.506E2a 1 .000 
  
Continuity Correctionb 145.010 1 .000 
  
Likelihood Ratio 104.755 1 .000 
  
Fisher's Exact Test    .000 .000 
Linear-by-Linear Association 150.197 1 .000 
  
N of Valid Casesb 382 
    
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 6,27. 
b. Computed only for a 2x2 table     
 
